data_3grx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3grx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.459 HD22 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 105.312 -2.107 . . . . 1.0 105.312 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HE2' ' A' ' 18' ' ' LYS . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.431 HD22 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' CB ' HD22 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' C ' ' HG1' ' A' ' 10' ' ' THR . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 9' ' ' GLU . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 82' ' ' LYS . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.087 -1.449 . . . . 1.0 107.087 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' HD22 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 ' HA ' HD22 ' A' ' 36' ' ' ASN 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 HD22 ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 82' ' ' LYS . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.466 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.488 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 118.347 -0.835 . . . . 1.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 82' ' ' LYS . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.41 ' HH ' ' CG ' ' A' ' 66' ' ' ASP . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' CG ' ' HH ' ' A' ' 13' ' ' TYR . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 30' ' ' GLU . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.406 HD22 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HB3' HD22 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' THR . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 9' ' ' GLU . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -154.04 81.89 1.14 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.459 HD22 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' H ' HD22 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.65 0.241 . . . . 1.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -167.02 56.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.607 2.763 . . . . 1.0 106.806 166.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 122.004 0.907 . . . . 1.0 112.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -144.2 80.66 1.65 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.718 2.407 . . . . 1.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.126 -1.065 . . . . 1.0 108.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -104.0 72.39 1.09 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 -171.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.55 65.62 0.45 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 131.294 3.838 . . . . 1.0 111.963 175.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HE2' ' A' ' 18' ' ' LYS . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.73 54.92 0.26 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 163.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.431 HD22 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' CB ' HD22 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.88 79.29 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.75 74.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 151.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' C ' ' HG1' ' A' ' 10' ' ' THR . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 9' ' ' GLU . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.77 65.28 1.31 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 82' ' ' LYS . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.332 0.11 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -155.09 84.08 1.07 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.447 1.499 . . . . 1.0 107.087 167.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.598 ' CD2' ' HA1' ' A' ' 83' ' ' GSH . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HB3' HD22 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . 0.598 ' HA1' ' CD2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 120.555 0.216 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.52 72.04 0.96 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.42 2.288 . . . . 1.0 105.918 158.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 ' HA ' HD22 ' A' ' 36' ' ' ASN 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 HD22 ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.89 58.31 0.77 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 -164.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 82' ' ' LYS . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -159.27 83.29 0.77 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.925 0.89 . . . . 1.0 109.977 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' CE1' ' HA1' ' A' ' 83' ' ' GSH . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.466 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.466 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . 0.452 ' HA1' ' CE1' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.162 0.506 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.95 72.12 1.08 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.191 1.796 . . . . 1.0 106.535 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.834 0.349 . . . . 1.0 110.099 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.62 61.57 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.313 2.245 . . . . 1.0 107.527 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HZ3' ' C3 ' ' A' ' 83' ' ' GSH . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.488 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . 0.414 ' C3 ' ' HZ3' ' A' ' 8' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -157.87 85.46 0.89 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.884 1.674 . . . . 1.0 109.387 160.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 82' ' ' LYS . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.951 0.881 . . . . 1.0 112.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -144.34 71.45 1.31 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.41 ' HH ' ' CG ' ' A' ' 66' ' ' ASP . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' CG ' ' HH ' ' A' ' 13' ' ' TYR . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.532 0.682 . . . . 1.0 109.244 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -103.16 60.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' CE2' ' HA1' ' A' ' 83' ' ' GSH . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 30' ' ' GLU . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.406 HD22 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' HB3' HD22 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . 0.459 ' HA1' ' CE2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.057 0.456 . . . . 1.0 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.0 63.08 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 173.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 10' ' ' THR . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 9' ' ' GLU . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.444 ' HB3' ' SG2' ' A' ' 83' ' ' GSH . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . 0.444 ' SG2' ' HB3' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.659 0.266 . . . . 1.0 110.812 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 74.78 1.48 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.235 2.214 . . . . 1.0 106.333 -173.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.544 HG21 ' HE3' ' A' ' 18' ' ' LYS . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 43' ' ' MET . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 33' ' ' ILE . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 5' ' ' ILE . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 69' ' ' TYR . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 HD13 ' HG2' ' A' ' 40' ' ' ARG . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.623 HD21 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' H ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG2' HD13 ' A' ' 33' ' ' ILE . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HA ' HD11 ' A' ' 20' ' ' LEU . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' HE3' ' A' ' 39' ' ' LYS . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 52' ' ' VAL . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' LYS . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HE3' HD12 ' A' ' 31' ' ' LEU . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG2' HD13 ' A' ' 33' ' ' ILE . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 105.312 -2.107 . . . . 1.0 105.312 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 52' ' ' VAL . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' CB ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 68' ' ' LEU . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HG12 ' A' ' 55' ' ' ILE . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HD22 ' A' ' 81' ' ' LEU . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 65' ' ' TYR . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 20' ' ' LEU . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 52' ' ' VAL . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 80' ' ' LEU . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 57' ' ' ILE . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD22 HG21 ' A' ' 3' ' ' VAL . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.554 HG21 ' HE3' ' A' ' 18' ' ' LYS . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HE3' ' OD2' ' A' ' 72' ' ' ASP . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' OD2' ' HE3' ' A' ' 24' ' ' LYS . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HE ' ' HA3' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA3' ' HE ' ' A' ' 74' ' ' ARG . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.087 -1.449 . . . . 1.0 107.087 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 18' ' ' LYS . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' HG21 ' A' ' 5' ' ' ILE . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 HD11 HG12 ' A' ' 52' ' ' VAL 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 33' ' ' ILE . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 33' ' ' ILE . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.537 ' H ' HD21 ' A' ' 36' ' ' ASN . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 50' ' ' THR . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.651 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.478 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.485 HD11 ' CG1' ' A' ' 52' ' ' VAL . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB3' HD21 ' A' ' 36' ' ' ASN . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HE ' ' HB ' ' A' ' 33' ' ' ILE . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 33' ' ' ILE . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.433 HD21 ' HE3' ' A' ' 24' ' ' LYS . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HE3' HD21 ' A' ' 20' ' ' LEU . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 118.347 -0.835 . . . . 1.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HE1' ' A' ' 65' ' ' TYR . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 20' ' ' LEU . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD11 ' CG1' ' A' ' 52' ' ' VAL . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HB3' HD21 ' A' ' 36' ' ' ASN . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 52' ' ' VAL . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 36' ' ' ASN . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.438 HG21 ' HE3' ' A' ' 18' ' ' LYS . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 31' ' ' LEU . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' HG21 ' A' ' 5' ' ' ILE . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 68' ' ' LEU . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 20' ' ' LEU . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 6' ' ' TYR . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 21' ' ' LEU . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.416 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CB ' HD21 ' A' ' 36' ' ' ASN . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 53' ' ' PRO . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.55 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD11 HG11 ' A' ' 52' ' ' VAL . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 33' ' ' ILE . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -154.04 81.89 1.14 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.544 HG21 ' HE3' ' A' ' 18' ' ' LYS . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 43' ' ' MET . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 33' ' ' ILE . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 5' ' ' ILE . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 69' ' ' TYR . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 HD13 ' HG2' ' A' ' 40' ' ' ARG . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.623 HD21 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' H ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG2' HD13 ' A' ' 33' ' ' ILE . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HA ' HD11 ' A' ' 20' ' ' LEU . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.65 0.241 . . . . 1.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -167.02 56.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.607 2.763 . . . . 1.0 106.806 166.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' HE3' ' A' ' 39' ' ' LYS . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 52' ' ' VAL . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' LYS . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HE3' HD12 ' A' ' 31' ' ' LEU . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG2' HD13 ' A' ' 33' ' ' ILE . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 122.004 0.907 . . . . 1.0 112.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -144.2 80.66 1.65 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.718 2.407 . . . . 1.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.126 -1.065 . . . . 1.0 108.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -104.0 72.39 1.09 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 -171.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.55 65.62 0.45 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 131.294 3.838 . . . . 1.0 111.963 175.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.73 54.92 0.26 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 163.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 52' ' ' VAL . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' CB ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.88 79.29 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 68' ' ' LEU . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HG12 ' A' ' 55' ' ' ILE . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.75 74.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 151.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HD22 ' A' ' 81' ' ' LEU . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 65' ' ' TYR . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 20' ' ' LEU . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 52' ' ' VAL . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 80' ' ' LEU . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 57' ' ' ILE . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD22 HG21 ' A' ' 3' ' ' VAL . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.77 65.28 1.31 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.554 HG21 ' HE3' ' A' ' 18' ' ' LYS . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HE3' ' OD2' ' A' ' 72' ' ' ASP . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' OD2' ' HE3' ' A' ' 24' ' ' LYS . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HE ' ' HA3' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA3' ' HE ' ' A' ' 74' ' ' ARG . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.332 0.11 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -155.09 84.08 1.07 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.447 1.499 . . . . 1.0 107.087 167.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 18' ' ' LYS . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CD2' ' HA1' ' A' ' 83' ' ' GSH . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' HG21 ' A' ' 5' ' ' ILE . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GSH . . . . . 0.583 ' HA1' ' CD2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 120.555 0.216 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.52 72.04 0.96 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.42 2.288 . . . . 1.0 105.918 158.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.514 HD11 HG12 ' A' ' 52' ' ' VAL 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 33' ' ' ILE . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 33' ' ' ILE . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.89 58.31 0.77 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 -164.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -159.27 83.29 0.77 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.925 0.89 . . . . 1.0 109.977 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CE1' ' HA1' ' A' ' 83' ' ' GSH . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.537 ' H ' HD21 ' A' ' 36' ' ' ASN . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 50' ' ' THR . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.651 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.478 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GSH . . . . . 0.428 ' HA1' ' CE1' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.162 0.506 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.95 72.12 1.08 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.191 1.796 . . . . 1.0 106.535 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.485 HD11 ' CG1' ' A' ' 52' ' ' VAL . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB3' HD21 ' A' ' 36' ' ' ASN . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HE ' ' HB ' ' A' ' 33' ' ' ILE . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 33' ' ' ILE . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.834 0.349 . . . . 1.0 110.099 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.62 61.57 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.313 2.245 . . . . 1.0 107.527 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD21 ' HE3' ' A' ' 24' ' ' LYS . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HE3' HD21 ' A' ' 20' ' ' LEU . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GSH . . . . . 0.435 HG13 ' CD2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -157.87 85.46 0.89 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.884 1.674 . . . . 1.0 109.387 160.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HE1' ' A' ' 65' ' ' TYR . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 20' ' ' LEU . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD11 ' CG1' ' A' ' 52' ' ' VAL . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HB3' HD21 ' A' ' 36' ' ' ASN . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 52' ' ' VAL . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.951 0.881 . . . . 1.0 112.571 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -144.34 71.45 1.31 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 36' ' ' ASN . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.532 0.682 . . . . 1.0 109.244 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -103.16 60.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.438 HG21 ' HE3' ' A' ' 18' ' ' LYS . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 31' ' ' LEU . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CE2' ' HA1' ' A' ' 83' ' ' GSH . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' HG21 ' A' ' 5' ' ' ILE . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 68' ' ' LEU . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 20' ' ' LEU . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 6' ' ' TYR . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 21' ' ' LEU . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GSH . . . . . 0.477 ' HA1' ' CE2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.057 0.456 . . . . 1.0 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.0 63.08 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 173.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB3' ' SG2' ' A' ' 83' ' ' GSH . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.416 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CB ' HD21 ' A' ' 36' ' ' ASN . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 53' ' ' PRO . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GSH . . . . . 0.47 ' SG2' ' HB3' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.659 0.266 . . . . 1.0 110.812 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 74.78 1.48 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.235 2.214 . . . . 1.0 106.333 -173.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.55 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD11 HG11 ' A' ' 52' ' ' VAL . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 33' ' ' ILE . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.544 HG21 ' HE3' ' A' ' 18' ' ' LYS . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 43' ' ' MET . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 33' ' ' ILE . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 5' ' ' ILE . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 69' ' ' TYR . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 HD13 ' HG2' ' A' ' 40' ' ' ARG . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.623 HD21 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' H ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG2' HD13 ' A' ' 33' ' ' ILE . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HA ' HD11 ' A' ' 20' ' ' LEU . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 106.806 -1.553 . . . . 1.0 106.806 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' HE3' ' A' ' 39' ' ' LYS . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 52' ' ' VAL . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' LYS . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HE3' HD12 ' A' ' 31' ' ' LEU . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG2' HD13 ' A' ' 33' ' ' ILE . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 105.312 -2.107 . . . . 1.0 105.312 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 111.963 0.357 . . . . 1.0 111.963 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 52' ' ' VAL . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' CB ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 68' ' ' LEU . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HG12 ' A' ' 55' ' ' ILE . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HD22 ' A' ' 81' ' ' LEU . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 65' ' ' TYR . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 20' ' ' LEU . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 52' ' ' VAL . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 80' ' ' LEU . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 57' ' ' ILE . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD22 HG21 ' A' ' 3' ' ' VAL . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.554 HG21 ' HE3' ' A' ' 18' ' ' LYS . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HE3' ' OD2' ' A' ' 72' ' ' ASP . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' OD2' ' HE3' ' A' ' 24' ' ' LYS . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HE ' ' HA3' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA3' ' HE ' ' A' ' 74' ' ' ARG . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.087 -1.449 . . . . 1.0 107.087 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 18' ' ' LYS . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' HG21 ' A' ' 5' ' ' ILE . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' HA ' HD21 ' A' ' 36' ' ' ASN 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.525 HD21 ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 33' ' ' ILE . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 33' ' ' ILE . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.443 HE22 HD22 ' A' ' 80' ' ' LEU . 27.3 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HE22 ' A' ' 60' ' ' GLN . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.537 ' H ' HD21 ' A' ' 36' ' ' ASN . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 50' ' ' THR . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.651 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.485 HD11 ' CG1' ' A' ' 52' ' ' VAL . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB3' HD21 ' A' ' 36' ' ' ASN . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HE ' ' HB ' ' A' ' 33' ' ' ILE . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 33' ' ' ILE . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.433 HD21 ' HE3' ' A' ' 24' ' ' LYS . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HE3' HD21 ' A' ' 20' ' ' LEU . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 118.347 -0.835 . . . . 1.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HE1' ' A' ' 65' ' ' TYR . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 20' ' ' LEU . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 HD11 ' CG1' ' A' ' 52' ' ' VAL . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HB3' HD21 ' A' ' 36' ' ' ASN . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 52' ' ' VAL . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.445 HD21 ' H ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HD21 ' A' ' 36' ' ' ASN . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.438 HG21 ' HE3' ' A' ' 18' ' ' LYS . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 31' ' ' LEU . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' HG21 ' A' ' 5' ' ' ILE . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 68' ' ' LEU . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 20' ' ' LEU . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 6' ' ' TYR . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 21' ' ' LEU . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.416 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CB ' HD21 ' A' ' 36' ' ' ASN . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 53' ' ' PRO . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.55 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD11 HG11 ' A' ' 52' ' ' VAL . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 33' ' ' ILE . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -154.04 81.89 1.14 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.494 -1.669 . . . . 1.0 106.494 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.96 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -120.2 146.89 45.59 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.839 1.656 . . . . 1.0 107.81 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.544 HG21 ' HE3' ' A' ' 18' ' ' LYS . 12.8 tt -142.8 124.03 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 123.024 0.53 . . . . 1.0 109.689 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 43' ' ' MET . 45.7 m-85 -75.87 137.02 40.16 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.676 169.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -138.96 162.83 33.93 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.324 1.85 . . . . 1.0 108.329 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 33' ' ' ILE . 37.9 ttmt -142.21 139.25 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.746 -2.316 . . . . 1.0 104.746 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -55.81 29.93 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.401 1.063 . . . . 1.0 108.254 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -86.15 78.24 9.42 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.1 t -172.4 104.03 0.34 Allowed Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.776 1.63 . . . . 1.0 108.2 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.98 -29.04 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 119.953 1.019 . . . . 1.0 111.458 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.416 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.5 t80 -58.43 -33.57 69.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 1.0 110.819 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -54.37 43.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.878 1.271 . . . . 1.0 109.766 170.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -68.15 -30.14 69.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 118.589 -0.719 . . . . 1.0 112.724 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -47.13 -55.0 9.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.335 1.454 . . . . 1.0 109.604 168.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -57.92 -26.63 62.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 113.437 0.903 . . . . 1.0 113.437 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HE3' HG21 ' A' ' 5' ' ' ILE . 1.5 mmmm -76.37 -31.84 58.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 117.94 -1.028 . . . . 1.0 112.736 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.35 83.76 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.281 -0.866 . . . . 1.0 109.883 170.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 69' ' ' TYR . 2.3 tt -67.82 -58.8 3.98 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.445 -0.946 . . . . 1.0 108.445 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.78 -32.36 71.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.771 -0.633 . . . . 1.0 110.436 -172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 t -74.29 -42.62 59.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.309 0.959 . . . . 1.0 110.948 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t -53.27 -44.51 68.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.515 1.052 . . . . 1.0 110.646 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -81.62 1.16 35.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.653 1.581 . . . . 1.0 112.526 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 57.85 36.94 82.33 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.693 1.133 . . . . 1.0 112.781 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.71 149.11 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 121.371 -1.076 . . . . 1.0 109.45 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.25 57.62 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 127.157 2.183 . . . . 1.0 108.642 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -73.92 168.59 19.16 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.545 -0.722 . . . . 1.0 110.364 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -127.41 106.05 8.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.903 -2.628 . . . . 1.0 103.903 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -84.1 136.43 34.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -117.98 88.24 30.7 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.174 1.789 . . . . 1.0 108.799 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.22 116.38 3.56 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.725 2.283 . . . . 1.0 109.457 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 HD13 ' HG2' ' A' ' 40' ' ' ARG . 1.2 pt -102.34 18.56 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.85 1.66 . . . . 1.0 111.27 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -72.29 0.22 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.62 31.54 2.44 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.328 -0.857 . . . . 1.0 113.233 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.623 HD21 ' H ' ' A' ' 39' ' ' LYS . 4.1 t-20 -156.07 141.65 17.77 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 119.256 1.528 . . . . 1.0 110.551 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -126.21 -16.37 5.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.67 1.188 . . . . 1.0 113.495 168.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.03 -72.11 0.13 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.373 0.988 . . . . 1.0 111.008 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' H ' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -58.55 -27.78 64.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.566 0.746 . . . . 1.0 112.137 177.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG2' HD13 ' A' ' 33' ' ' ILE . 2.7 tmm_? -55.13 -57.54 11.35 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.53 -13.63 60.7 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.385 -0.822 . . . . 1.0 111.805 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -69.75 -39.44 76.73 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 106.998 -1.482 . . . . 1.0 106.998 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 38.8 ttp -55.0 -44.92 74.97 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.965 1.306 . . . . 1.0 110.958 171.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -76.07 -30.11 58.23 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.897 -1.127 . . . . 1.0 112.193 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -65.16 -45.32 85.44 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.818 1.19 . . . . 1.0 110.62 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.7 p -121.95 -17.15 7.39 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.308 1.225 . . . . 1.0 114.308 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.22 -15.47 39.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.066 -0.852 . . . . 1.0 112.881 -169.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -85.43 144.67 27.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.877 1.839 . . . . 1.0 109.992 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.0 p -94.11 -31.43 14.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.173 0.589 . . . . 1.0 112.322 -176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.3 p -81.97 162.3 22.72 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.329 0.651 . . . . 1.0 112.264 -168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 m -112.92 163.93 16.73 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 126.671 1.988 . . . . 1.0 111.245 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 80.7 Cg_endo -70.88 165.5 79.64 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 N-CA-C 109.484 -1.006 . . . . 1.0 109.484 -11.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -143.49 136.93 28.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.54 -2.393 . . . . 1.0 104.54 168.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.29 147.41 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.14 144.02 51.11 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.201 -2.148 . . . . 1.0 105.201 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.97 114.07 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.864 -2.643 . . . . 1.0 103.864 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 54.79 46.0 25.46 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.338 1.066 . . . . 1.0 109.913 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.08 -7.21 0.3 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 129.22 3.008 . . . . 1.0 115.042 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -77.29 134.23 38.59 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.92 154.89 33.22 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.978 0.911 . . . . 1.0 110.008 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 mm -100.18 -77.43 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.47 -1.307 . . . . 1.0 107.47 169.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.14 -143.57 10.06 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 105.773 -2.931 . . . . 1.0 105.773 -168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.76 -165.69 35.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.705 1.145 . . . . 1.0 112.848 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.1 t80 -76.81 -47.55 21.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.356 -0.83 . . . . 1.0 111.903 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.17 -37.15 79.29 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -57.69 -50.87 71.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.409 1.084 . . . . 1.0 108.794 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 tp -59.06 -46.76 87.43 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 117.896 -1.049 . . . . 1.0 111.892 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HA ' HD11 ' A' ' 20' ' ' LEU . 15.5 t80 -51.29 -53.17 38.34 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.201 1.364 . . . . 1.0 110.679 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.61 -44.32 94.29 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.73 -32.23 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.369 0.667 . . . . 1.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -71.87 -59.03 2.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.851 -1.156 . . . . 1.0 109.716 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.44 -22.21 66.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.091 0.774 . . . . 1.0 113.091 -170.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -16.37 59.47 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.156 0.983 . . . . 1.0 112.339 171.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.88 15.14 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.761 -1.022 . . . . 1.0 112.558 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.02 -35.21 6.15 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 119.778 1.789 . . . . 1.0 110.454 169.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 tt -73.69 -54.63 7.65 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.893 -1.521 . . . . 1.0 106.893 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -50.32 -52.84 50.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 115.414 1.635 . . . . 1.0 115.414 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.78 -11.31 27.61 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 121.41 1.539 . . . . 1.0 114.366 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.67 -8.03 59.37 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.598 1.09 . . . . 1.0 111.479 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -21.84 62.97 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.959 -0.463 . . . . 1.0 109.79 171.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.065 -1.445 . . . . 1.0 107.393 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 111.65 0.241 . . . . 1.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -167.02 56.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.607 2.763 . . . . 1.0 106.806 166.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.08 98.41 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -96.94 144.9 26.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.159 -1.052 . . . . 1.0 108.159 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -138.17 109.17 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.072 1.349 . . . . 1.0 108.487 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -74.56 133.46 42.24 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 121.677 -0.64 . . . . 1.0 109.28 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.7 p -145.2 169.74 17.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.542 1.137 . . . . 1.0 108.882 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.93 155.83 49.24 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.178 -2.156 . . . . 1.0 105.178 168.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 5.2 tp10 -65.85 167.11 10.0 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.253 0.4 OUTLIER 75.72 -48.21 0.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.321 2.248 . . . . 1.0 112.812 -175.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 90.4 m -73.38 110.28 8.41 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.929 1.24 . . . . 1.0 111.232 -170.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.04 -32.35 64.67 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 121.096 1.427 . . . . 1.0 113.673 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -54.89 -29.36 55.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.637 1.562 . . . . 1.0 110.996 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -58.45 8.46 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.099 1.359 . . . . 1.0 112.135 168.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -73.46 -32.58 64.42 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.127 -0.983 . . . . 1.0 111.844 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 73.0 mtp180 -54.51 -42.69 71.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.78 0.832 . . . . 1.0 110.003 169.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 -26.19 67.05 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.295 -0.878 . . . . 1.0 112.735 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -68.99 -46.33 68.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 117.645 -1.169 . . . . 1.0 109.756 170.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.28 -23.92 25.67 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.761 1.164 . . . . 1.0 112.2 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -75.49 -70.16 0.44 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 118.27 -0.871 . . . . 1.0 110.467 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.63 -35.69 66.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.246 0.93 . . . . 1.0 113.081 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -70.39 -45.02 66.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.306 1.442 . . . . 1.0 109.945 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 t -63.47 -36.73 84.72 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.867 1.212 . . . . 1.0 110.03 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -73.91 -1.72 20.89 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.313 1.045 . . . . 1.0 111.77 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.76 42.93 99.64 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 124.626 1.108 . . . . 1.0 112.254 171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.06 142.35 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.5 m -74.29 127.82 33.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -136.63 153.19 51.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.011 0.924 . . . . 1.0 110.434 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -109.83 101.57 10.42 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 128.936 2.895 . . . . 1.0 104.563 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.86 147.94 52.57 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.44 169.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' HE3' ' A' ' 39' ' ' LYS . 3.2 mm? -121.04 90.21 46.89 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.834 -2.654 . . . . 1.0 103.834 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.8 102.41 0.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.75 1.633 . . . . 1.0 108.221 171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 52' ' ' VAL . 2.3 pt -87.92 18.49 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.128 0.971 . . . . 1.0 110.56 169.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 29.5 t70 -66.57 -65.42 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.891 1.223 . . . . 1.0 109.86 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.14 38.94 3.09 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.413 1.482 . . . . 1.0 111.37 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' LYS . 11.9 t30 -153.21 131.45 11.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.277 1.031 . . . . 1.0 110.207 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.41 -18.69 13.18 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.586 0.755 . . . . 1.0 112.671 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -65.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.512 1.051 . . . . 1.0 111.14 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.474 ' HE3' HD12 ' A' ' 31' ' ' LEU . 15.1 ttpt -67.4 -25.61 66.03 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.967 -1.083 . . . . 1.0 111.401 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG2' HD13 ' A' ' 33' ' ' ILE . 1.9 tmm_? -54.0 -53.68 49.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.382 0.537 . . . . 1.0 109.684 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.7 -31.46 70.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.491 0.717 . . . . 1.0 111.604 -173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.32 -44.43 83.38 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.335 0.516 . . . . 1.0 110.138 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -54.46 -34.98 62.52 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.188 0.995 . . . . 1.0 111.341 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.3 mt -52.11 -57.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -74.53 -0.69 18.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.403 1.081 . . . . 1.0 112.897 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -104.46 -9.47 18.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.702 1.137 . . . . 1.0 112.326 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 71.3 p -124.01 -31.5 3.37 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.39 1.45 . . . . 1.0 113.678 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.33 10.8 84.18 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.836 -0.98 . . . . 1.0 111.408 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -130.76 144.26 51.32 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.929 1.864 . . . . 1.0 109.158 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -89.25 -21.32 23.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.7 p -84.16 143.58 29.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 121.479 -0.763 . . . . 1.0 112.062 -169.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.79 168.29 15.19 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 123.789 0.835 . . . . 1.0 110.644 168.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.26 159.61 97.5 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 N-CA-C 108.39 -1.427 . . . . 1.0 108.39 -11.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -139.05 142.13 38.21 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.028 -1.841 . . . . 1.0 106.028 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.92 146.09 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -130.39 145.72 51.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.9 mt -131.41 123.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 103.502 -2.777 . . . . 1.0 103.502 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 54.19 37.49 27.29 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.212 1.005 . . . . 1.0 110.944 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.61 -6.71 1.16 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.502 3.121 . . . . 1.0 114.723 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -73.78 112.59 10.04 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 120.187 1.358 . . . . 1.0 108.16 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -65.13 132.88 50.31 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.07 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.817 -1.179 . . . . 1.0 107.817 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.48 -149.74 21.82 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 103.777 -3.729 . . . . 1.0 103.777 -168.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.09 -160.12 36.24 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.964 1.313 . . . . 1.0 111.479 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -66.87 -58.21 5.47 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.352 2.261 . . . . 1.0 111.589 -174.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.89 -25.23 67.07 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.733 1.151 . . . . 1.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -65.17 -51.07 63.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.3 -44.52 91.38 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-O 118.588 -0.72 . . . . 1.0 111.94 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -48.8 -53.4 19.35 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.37 1.868 . . . . 1.0 110.033 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.63 93.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.626 -0.226 . . . . 1.0 111.032 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -36.44 84.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.169 0.588 . . . . 1.0 110.48 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.34 -55.15 34.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.961 -1.087 . . . . 1.0 108.552 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.71 -26.44 68.66 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.123 0.786 . . . . 1.0 113.123 -172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -19.18 60.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.253 1.021 . . . . 1.0 110.775 173.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.62 23.23 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.525 1.536 . . . . 1.0 111.759 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.61 -13.07 23.25 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 120.281 2.041 . . . . 1.0 113.279 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -42.02 62.3 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -49.87 -52.72 49.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 1.0 113.468 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.3 -15.57 20.03 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.889 2.393 . . . . 1.0 114.396 175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -30.13 38.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.552 1.069 . . . . 1.0 110.774 174.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.46 -47.24 66.57 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.033 0.933 . . . . 1.0 109.811 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt . . . . . 0 C--O 1.256 1.426 0 C-N-CA 126.871 2.068 . . . . 1.0 111.481 170.587 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 122.004 0.907 . . . . 1.0 112.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -144.2 80.66 1.65 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 127.718 2.407 . . . . 1.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.46 97.39 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.09 152.13 24.53 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.449 -0.782 . . . . 1.0 109.118 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt -144.3 116.38 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.527 1.131 . . . . 1.0 108.165 169.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.82 133.92 43.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 p -141.92 162.9 34.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.715 0.806 . . . . 1.0 110.52 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HE3' ' SG ' ' A' ' 11' ' ' CYS . 6.1 ttmt -140.32 162.12 36.04 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.964 -1.495 . . . . 1.0 106.964 168.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -62.41 -73.78 0.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.2 87.82 3.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.687 -1.227 . . . . 1.0 107.687 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 8' ' ' LYS . 16.9 m -164.84 98.75 0.84 Allowed Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 128.739 2.816 . . . . 1.0 105.348 169.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.89 -37.94 32.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 121.887 1.71 . . . . 1.0 110.151 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -62.66 1.34 0.39 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.291 1.836 . . . . 1.0 112.854 169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 t -97.64 -43.02 7.38 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.104 -1.814 . . . . 1.0 106.104 167.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.26 -25.98 60.92 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.199 -0.938 . . . . 1.0 112.04 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -51.6 -47.87 63.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 1.0 110.495 169.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -26.03 68.52 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.271 -0.893 . . . . 1.0 112.062 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -76.18 -45.6 32.51 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 117.336 -1.316 . . . . 1.0 109.762 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 -27.22 55.48 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 120.853 1.66 . . . . 1.0 111.722 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.04 -69.93 0.47 Allowed 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.183 0.901 . . . . 1.0 110.183 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.39 -33.79 74.26 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 123.435 0.694 . . . . 1.0 111.312 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.9 t -78.68 -30.3 46.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.133 -1.413 . . . . 1.0 109.887 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.3 t -60.04 -41.9 93.28 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 121.755 2.07 . . . . 1.0 107.802 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -77.31 -8.34 57.47 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.068 1.136 . . . . 1.0 114.068 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.82 69.17 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.274 1.416 . . . . 1.0 114.765 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.16 142.65 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 119.722 1.761 . . . . 1.0 110.112 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.0 t -75.07 163.51 27.51 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.81 154.24 21.94 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.666 1.986 . . . . 1.0 107.586 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -92.5 100.81 13.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 102.053 -3.314 . . . . 1.0 102.053 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.49 137.75 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.163 -0.472 . . . . 1.0 109.935 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.0 79.98 50.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 127.443 2.297 . . . . 1.0 108.261 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -61.53 135.0 54.38 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.965 2.443 . . . . 1.0 110.698 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.54 15.32 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 126.672 1.989 . . . . 1.0 110.509 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -65.0 -59.2 4.42 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.476 -0.765 . . . . 1.0 110.695 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.55 14.09 65.99 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 118.958 0.799 . . . . 1.0 111.98 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -136.12 104.61 5.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.142 1.377 . . . . 1.0 109.047 -168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.37 -12.53 29.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.266 0.626 . . . . 1.0 112.439 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.71 -67.86 0.39 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.042 0.937 . . . . 1.0 109.851 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.07 -18.96 64.82 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.09 -0.957 . . . . 1.0 111.212 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.36 -33.0 74.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.721 1.146 . . . . 1.0 111.078 170.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -72.87 -49.1 32.0 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -57.53 -34.48 69.18 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.933 0.493 . . . . 1.0 111.759 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.2 ttp -56.81 -37.08 70.69 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.648 0.779 . . . . 1.0 111.037 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.19 -52.7 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.246 -1.39 . . . . 1.0 107.246 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -53.51 -43.79 68.57 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.455 0.57 . . . . 1.0 111.297 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -70.22 -19.6 63.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.211 -0.9 . . . . 1.0 112.557 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -121.15 -14.34 8.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 54.42 23.51 27.24 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.924 -0.931 . . . . 1.0 111.833 -168.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -147.31 144.1 28.54 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.071 2.148 . . . . 1.0 106.871 -173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.89 -21.47 22.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.863 1.265 . . . . 1.0 112.841 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -80.14 143.79 33.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 120.788 0.328 . . . . 1.0 111.83 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.54 153.17 38.91 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.945 1.698 . . . . 1.0 107.4 168.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.95 161.14 89.23 Favored 'Cis proline' 0 N--CA 1.446 -1.3 0 N-CA-C 110.02 -0.8 . . . . 1.0 110.02 -6.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -123.86 118.42 27.07 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 103.851 -2.648 . . . . 1.0 103.851 168.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -95.84 148.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 104.957 -2.238 . . . . 1.0 104.957 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.58 149.39 46.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.471 -2.048 . . . . 1.0 105.471 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.8 mt -135.16 115.91 19.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.887 -2.264 . . . . 1.0 104.887 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 54.33 40.06 31.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.917 0.865 . . . . 1.0 110.678 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 70.94 -3.26 2.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 129.16 2.984 . . . . 1.0 113.988 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -74.32 117.04 15.68 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -85.83 134.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.036 0.935 . . . . 1.0 108.486 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mm -84.08 -62.58 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.3 -24.29 2.67 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.656 1.598 . . . . 1.0 113.159 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.81 39.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.673 -1.771 . . . . 1.0 108.673 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -74.6 -46.92 35.39 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.434 -0.793 . . . . 1.0 110.584 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -61.65 -32.81 72.99 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.952 -0.759 . . . . 1.0 108.952 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -61.12 -51.95 66.92 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.305 -0.628 . . . . 1.0 109.305 170.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.29 -46.72 82.87 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 118.173 -0.917 . . . . 1.0 111.535 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.9 -53.22 60.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.26 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.974 0.51 . . . . 1.0 110.9 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -56.43 -45.56 80.7 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.875 1.27 . . . . 1.0 110.375 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.32 -55.93 10.34 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.242 1.017 . . . . 1.0 109.136 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.58 -22.66 63.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.453 1.501 . . . . 1.0 114.606 -169.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -86.15 -11.54 52.3 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 114.406 1.261 . . . . 1.0 114.406 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.07 26.63 11.1 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.81 1.195 . . . . 1.0 112.507 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.28 -44.99 6.02 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 120.191 1.996 . . . . 1.0 111.699 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -45.38 52.75 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.382 -1.34 . . . . 1.0 107.382 -172.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -51.04 -50.28 76.07 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 113.515 0.932 . . . . 1.0 113.515 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.39 -21.16 26.71 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 CA-C-N 121.763 1.665 . . . . 1.0 114.561 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.0 mt -75.12 -7.45 53.8 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.324 1.42 . . . . 1.0 111.23 169.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 16.82 1.89 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.882 1.273 . . . . 1.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 168.747 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 108.126 -1.065 . . . . 1.0 108.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -104.0 72.39 1.09 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.473 -1.306 . . . . 1.0 107.473 -171.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.81 122.08 26.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.695 -1.593 . . . . 1.0 106.901 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -131.33 157.18 44.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.343 0.974 . . . . 1.0 109.753 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.17 114.06 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.143 1.377 . . . . 1.0 108.427 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -73.97 135.5 43.2 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -145.06 167.03 23.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.788 1.635 . . . . 1.0 109.642 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -138.8 162.56 34.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.348 -1.723 . . . . 1.0 106.348 168.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -65.43 168.36 7.35 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.7 p 56.39 55.81 6.27 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.714 1.206 . . . . 1.0 110.891 173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.7 t -158.46 104.86 1.66 Allowed Pre-proline 0 C--O 1.235 0.336 0 O-C-N 121.296 -0.878 . . . . 1.0 110.557 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.02 -39.03 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.411 1.407 . . . . 1.0 111.842 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 15.3 t80 -54.3 -35.74 62.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.62 1.168 . . . . 1.0 110.586 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -64.27 -55.92 18.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.495 1.118 . . . . 1.0 109.544 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -59.33 -45.18 92.05 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.634 1.106 . . . . 1.0 112.448 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -47.31 -47.11 25.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.926 1.291 . . . . 1.0 112.049 169.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -65.58 -26.84 68.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.851 1.056 . . . . 1.0 113.851 -173.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -35.51 60.35 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 117.414 -1.279 . . . . 1.0 110.452 170.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.55 -30.14 66.91 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.975 1.261 . . . . 1.0 111.703 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -67.21 -59.09 3.72 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.933 0.788 . . . . 1.0 109.099 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -60.97 -34.99 75.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.612 1.165 . . . . 1.0 111.357 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -66.95 -45.14 78.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.283 1.833 . . . . 1.0 109.776 174.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -62.47 -14.08 37.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.655 1.116 . . . . 1.0 111.991 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -102.62 2.78 36.49 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.546 1.538 . . . . 1.0 111.928 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.23 29.49 71.41 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.136 0.88 . . . . 1.0 112.409 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.52 154.7 3.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 119.191 1.496 . . . . 1.0 107.342 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.5 t -99.05 105.15 17.23 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.243 -1.762 . . . . 1.0 106.243 170.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -115.33 -177.59 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.83 1.252 . . . . 1.0 109.387 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -137.05 106.15 5.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.38 141.76 58.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 169.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -134.13 98.03 14.54 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.11 1.364 . . . . 1.0 109.173 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.16 111.44 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.891 3.061 . . . . 1.0 111.914 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -28.32 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 120.474 -1.391 . . . . 1.0 111.21 168.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.55 -42.3 87.55 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -168.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.7 73.02 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.622 -0.543 . . . . 1.0 112.752 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.8 87.85 2.25 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.288 1.544 . . . . 1.0 108.002 -170.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.05 -25.58 22.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.953 0.901 . . . . 1.0 112.17 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.98 -61.89 2.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.982 0.913 . . . . 1.0 109.871 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -68.87 -20.69 64.28 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.622 -0.674 . . . . 1.0 111.755 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.79 -43.49 90.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.558 1.072 . . . . 1.0 109.351 169.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.1 -47.39 77.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.674 0.67 . . . . 1.0 110.573 172.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.81 -43.24 72.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.568 0.699 . . . . 1.0 109.968 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 14.1 tmm? -60.81 -24.02 65.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.288 1.435 . . . . 1.0 112.323 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.6 mt -60.39 -47.11 93.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 1.0 109.009 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -68.26 -33.4 74.3 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 121.422 -0.799 . . . . 1.0 110.392 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -64.29 -16.85 62.94 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 117.585 -1.198 . . . . 1.0 112.796 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.6 p -138.41 -11.37 1.41 Allowed 'General case' 0 C--N 1.342 0.261 0 N-CA-C 118.774 2.879 . . . . 1.0 118.774 -168.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.98 18.55 57.47 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 120.479 1.491 . . . . 1.0 112.239 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -143.92 -178.81 6.11 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.714 2.005 . . . . 1.0 108.608 -169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -135.98 -40.26 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.743 1.217 . . . . 1.0 109.55 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -77.08 143.57 39.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.363 -0.836 . . . . 1.0 110.78 -169.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.94 162.58 26.48 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.822 1.249 . . . . 1.0 112.078 170.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 29.3 Cg_endo -79.75 163.7 82.92 Favored 'Cis proline' 0 C--N 1.351 0.699 0 O-C-N 122.285 0.624 . . . . 1.0 110.51 -7.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -143.06 147.97 35.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.675 -1.602 . . . . 1.0 106.675 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.14 155.81 24.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.288 -1.745 . . . . 1.0 106.288 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -141.44 147.64 38.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 127.036 2.134 . . . . 1.0 106.503 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.68 116.67 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.01 36.29 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.057 1.343 . . . . 1.0 109.599 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.64 1.65 1.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.814 2.846 . . . . 1.0 114.667 -171.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -78.84 107.72 11.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 171.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -58.1 130.92 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.363 1.865 . . . . 1.0 110.892 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mm -78.5 -65.45 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.192 -1.04 . . . . 1.0 108.192 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.56 -149.5 20.07 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 106.175 -2.77 . . . . 1.0 106.175 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.52 -166.5 32.55 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.292 0.949 . . . . 1.0 112.392 170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 39.9 t80 -70.58 -51.27 29.55 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.051 0.94 . . . . 1.0 111.476 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.37 -26.65 68.11 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.85 -50.69 55.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.715 1.206 . . . . 1.0 108.134 172.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.93 -47.72 79.96 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 119.08 0.855 . . . . 1.0 110.81 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -53.06 61.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.476 -1.675 . . . . 1.0 106.476 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.9 -31.22 72.33 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.678 -0.638 . . . . 1.0 111.26 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -40.23 73.34 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.7 1.2 . . . . 1.0 109.623 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.34 -54.29 45.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.953 -1.092 . . . . 1.0 110.107 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.14 -24.09 62.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.862 1.265 . . . . 1.0 113.646 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -17.7 55.32 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.024 0.929 . . . . 1.0 112.184 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.57 60.41 3.23 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 124.889 1.233 . . . . 1.0 110.131 -168.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.3 -25.97 1.02 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 118.563 1.181 . . . . 1.0 112.911 169.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.48 -49.63 25.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 105.02 -2.215 . . . . 1.0 105.02 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -59.96 -51.17 82.55 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 115.546 -0.752 . . . . 1.0 112.053 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.04 -9.37 23.44 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.825 1.683 . . . . 1.0 114.866 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.81 -5.61 58.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.658 1.572 . . . . 1.0 111.644 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.74 -15.13 62.66 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.734 1.152 . . . . 1.0 110.167 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? . . . . . 0 C--O 1.247 0.942 0 C-N-CA 126.929 2.092 . . . . 1.0 111.291 -174.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.55 65.62 0.45 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 131.294 3.838 . . . . 1.0 111.963 175.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.7 t -92.25 100.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.982 -1.859 . . . . 1.0 105.982 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -117.16 144.26 44.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 1.0 107.852 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.51 118.15 41.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 124.62 1.168 . . . . 1.0 108.551 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -73.47 133.0 43.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.8 p -141.79 158.97 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.487 1.915 . . . . 1.0 107.917 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -148.67 148.57 30.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -66.93 168.32 10.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.208 1.803 . . . . 1.0 114.71 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 11.7 t 42.01 42.61 2.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.442 2.697 . . . . 1.0 112.127 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -148.82 93.4 4.24 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.62 -34.82 24.25 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-O 116.547 -1.522 . . . . 1.0 113.007 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.73 -29.03 69.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.908 2.14 . . . . 1.0 110.812 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.6 t -64.31 -57.19 10.1 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -63.87 -42.34 97.53 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.93 -0.481 . . . . 1.0 112.258 -172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -52.61 -36.25 56.01 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.559 1.544 . . . . 1.0 111.836 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -68.88 -26.91 65.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 118.701 -1.2 . . . . 1.0 113.519 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -31.57 57.89 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.535 -1.222 . . . . 1.0 111.008 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.65 67.17 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 119.797 1.181 . . . . 1.0 110.712 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.87 -63.08 1.26 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.778 0.717 . . . . 1.0 109.288 171.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.77 -30.82 71.05 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.939 -0.476 . . . . 1.0 111.719 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -73.81 -40.46 63.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.734 1.614 . . . . 1.0 109.641 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 t -56.77 -25.18 54.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.662 1.119 . . . . 1.0 111.301 169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -102.95 4.12 37.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.859 1.664 . . . . 1.0 113.005 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.17 71.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.416 1.007 . . . . 1.0 113.192 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -84.23 154.04 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.372 1.086 . . . . 1.0 110.193 -168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.4 102.42 14.66 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 168.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -125.59 145.41 50.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.657 -1.608 . . . . 1.0 106.657 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -89.28 98.65 11.89 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.431 -1.692 . . . . 1.0 106.431 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 139.1 58.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.306 -1.316 . . . . 1.0 107.596 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -134.13 96.46 15.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.04 1.736 . . . . 1.0 108.501 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -77.54 104.12 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.826 3.684 . . . . 1.0 108.447 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.36 2.86 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 118.25 -0.881 . . . . 1.0 111.323 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 17.9 t0 -73.22 163.64 27.83 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 120.301 1.41 . . . . 1.0 111.148 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.49 16.59 58.74 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.326 0.489 . . . . 1.0 112.339 -174.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.55 157.44 36.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.189 2.196 . . . . 1.0 108.808 -169.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.6 -26.07 2.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.707 1.203 . . . . 1.0 110.707 168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.21 -60.77 2.64 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.37 1.868 . . . . 1.0 111.048 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -69.68 -27.84 65.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.486 -0.759 . . . . 1.0 111.123 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.88 -40.92 97.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.222 1.374 . . . . 1.0 110.68 169.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.92 -27.71 69.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 119.547 1.067 . . . . 1.0 110.848 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -72.45 -38.62 68.23 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.712 1.142 . . . . 1.0 110.965 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.3 ttp -54.09 -30.74 49.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.809 0.844 . . . . 1.0 111.023 175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.47 -70.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.299 1.04 . . . . 1.0 109.658 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -68.0 -28.82 67.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.312 1.414 . . . . 1.0 112.394 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -53.24 -53.28 53.14 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.931 0.787 . . . . 1.0 109.95 172.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.0 p -95.96 -13.87 23.5 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.296 0.85 . . . . 1.0 113.296 -170.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.59 26.96 47.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.629 -1.095 . . . . 1.0 111.564 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -148.43 172.39 14.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 127.343 2.257 . . . . 1.0 107.813 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.6 p -112.76 -20.53 11.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 114.483 1.29 . . . . 1.0 114.483 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -118.06 156.36 28.75 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.839 0.745 . . . . 1.0 112.292 -168.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.09 168.74 19.89 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.038 1.335 . . . . 1.0 111.515 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.48 157.6 95.86 Favored 'Cis proline' 0 N--CA 1.458 -0.603 0 N-CA-C 108.719 -1.3 . . . . 1.0 108.719 -11.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -135.38 123.7 23.22 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 106.571 -1.64 . . . . 1.0 106.571 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.24 149.48 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.087 -1.82 . . . . 1.0 106.087 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -134.33 132.75 39.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 104.504 -2.406 . . . . 1.0 104.504 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 mt -132.43 124.7 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 105.195 -2.15 . . . . 1.0 105.195 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.44 40.89 19.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.792 1.237 . . . . 1.0 108.76 -169.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.98 -4.86 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 130.554 3.542 . . . . 1.0 115.687 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.03 127.94 34.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 120.42 1.464 . . . . 1.0 107.611 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -66.85 144.42 56.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.892 0.477 . . . . 1.0 110.235 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 mm -86.06 -88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.96 -44.15 0.15 Allowed Glycine 0 CA--C 1.527 0.797 0 O-C-N 121.458 -0.776 . . . . 1.0 113.35 -168.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.05 -170.48 43.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t80 -70.41 -55.05 9.98 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 118.027 0.913 . . . . 1.0 111.367 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -63.95 -30.44 71.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.755 0.788 . . . . 1.0 109.263 -173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -63.18 -53.73 48.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.244 1.818 . . . . 1.0 109.858 170.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.5 tp -56.64 -47.03 80.63 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 118.669 0.668 . . . . 1.0 110.665 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.18 -52.81 40.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.885 2.074 . . . . 1.0 108.79 177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.16 -44.5 95.29 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.912 -0.493 . . . . 1.0 109.932 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.37 -41.08 88.48 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.266 1.426 . . . . 1.0 110.566 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -64.78 -53.07 52.79 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.237 1.815 . . . . 1.0 110.289 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.62 -26.08 66.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.14 1.163 . . . . 1.0 114.14 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -77.75 -18.69 56.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.062 0.945 . . . . 1.0 112.468 169.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.07 11.33 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-O 117.607 -1.663 . . . . 1.0 111.833 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 -27.5 18.38 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 120.479 2.139 . . . . 1.0 110.143 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -73.69 -55.62 6.03 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 107.356 -1.35 . . . . 1.0 107.356 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -49.15 -50.44 63.62 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.387 -1.292 . . . . 1.0 113.754 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.81 -23.76 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.842 1.694 . . . . 1.0 112.796 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 mt -76.83 -6.88 54.14 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.421 1.009 . . . . 1.0 111.338 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.06 -40.16 76.29 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.866 1.212 . . . . 1.0 110.441 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 1.0 108.35 -177.321 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 113.043 0.757 . . . . 1.0 113.043 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.73 54.92 0.26 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.712 -0.661 . . . . 1.0 111.412 163.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.6 117.09 23.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.92 140.08 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.622 1.569 . . . . 1.0 106.771 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.71 112.14 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.245 1.418 . . . . 1.0 107.375 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -79.56 135.21 36.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.263 0.625 . . . . 1.0 110.007 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -139.76 158.9 43.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.975 1.31 . . . . 1.0 109.411 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -143.49 158.41 43.67 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.939 -1.101 . . . . 1.0 108.327 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -53.48 -70.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.65 1.98 . . . . 1.0 112.095 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -76.54 69.69 3.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.278 1.431 . . . . 1.0 109.611 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.7 t -166.83 96.36 0.69 Allowed Pre-proline 0 CA--C 1.539 0.534 0 O-C-N 120.906 -1.121 . . . . 1.0 111.179 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.01 -31.13 24.52 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.048 1.165 . . . . 1.0 111.803 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 44.2 t80 -60.37 -24.46 65.1 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.505 1.048 . . . . 1.0 111.555 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -69.18 -56.17 8.44 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -53.37 -44.43 68.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.774 0.715 . . . . 1.0 112.017 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -45.29 -48.49 13.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.374 1.47 . . . . 1.0 111.811 172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.49 -26.64 65.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 119.363 0.983 . . . . 1.0 113.447 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -37.45 57.18 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.314 0.961 . . . . 1.0 110.85 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.02 -37.02 68.62 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.926 0.785 . . . . 1.0 110.609 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.87 -63.37 1.23 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.07 -45.16 71.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 118.981 -0.533 . . . . 1.0 111.932 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.2 m -69.13 -35.31 76.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 117.988 -1.005 . . . . 1.0 112.423 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -59.48 -35.31 73.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.436 1.471 . . . . 1.0 110.718 170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -84.57 -1.09 55.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.848 1.259 . . . . 1.0 111.881 175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.56 24.99 62.59 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.843 1.211 . . . . 1.0 113.452 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -83.99 152.39 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 119.326 1.563 . . . . 1.0 109.223 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.3 m -94.17 134.93 36.11 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.025 2.13 . . . . 1.0 109.573 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -150.37 169.02 22.42 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.402 1.081 . . . . 1.0 108.896 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -114.58 106.35 14.15 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.229 -2.137 . . . . 1.0 105.229 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.62 139.24 51.32 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -125.27 94.34 43.48 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 125.77 1.628 . . . . 1.0 108.777 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.93 145.34 98.56 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.664 1.576 . . . . 1.0 111.233 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 52' ' ' VAL . 1.6 pt -136.73 -3.06 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.646 1.579 . . . . 1.0 111.937 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -66.55 -34.6 78.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.249 1.386 . . . . 1.0 111.106 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.89 10.76 60.6 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 1.0 112.349 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -148.55 93.21 2.11 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.509 1.154 . . . . 1.0 109.362 -168.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.9 -25.77 60.19 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.801 -0.562 . . . . 1.0 112.091 174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.67 -65.15 0.73 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.597 1.559 . . . . 1.0 111.248 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' CB ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -67.57 -16.84 64.4 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.342 -0.849 . . . . 1.0 111.06 177.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -67.46 -43.23 81.55 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 120.022 1.283 . . . . 1.0 109.55 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -46.89 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.209 1.004 . . . . 1.0 108.726 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -57.97 -52.75 64.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.277 1.031 . . . . 1.0 111.008 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.0 ttp -59.92 -38.27 81.86 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.126 -0.984 . . . . 1.0 112.073 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.92 -51.66 70.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.665 -1.606 . . . . 1.0 106.665 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -66.08 -24.81 66.78 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.613 0.642 . . . . 1.0 112.641 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -89.59 2.36 54.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.944 1.298 . . . . 1.0 112.971 174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 79.3 p -131.68 -19.55 2.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.322 1.419 . . . . 1.0 114.386 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.36 30.67 8.25 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.904 1.24 . . . . 1.0 112.314 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -128.57 -38.26 1.73 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.074 1.437 . . . . 1.0 114.225 -168.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.41 -13.97 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.648 1.179 . . . . 1.0 114.027 171.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.5 p -88.91 161.65 16.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.747 -0.595 . . . . 1.0 110.45 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.99 160.0 51.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.635 0.774 . . . . 1.0 113.014 168.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 94.4 Cg_endo -72.76 167.49 78.03 Favored 'Cis proline' 0 C--N 1.353 0.815 0 CA-C-N 118.475 0.491 . . . . 1.0 111.785 -1.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -138.03 141.59 40.37 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 104.103 -2.554 . . . . 1.0 104.103 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.91 151.66 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -131.13 140.49 49.98 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.013 -1.847 . . . . 1.0 106.013 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.6 mt -140.02 132.06 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 46.7 44.92 14.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.608 1.194 . . . . 1.0 110.987 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.77 -9.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.354 3.461 . . . . 1.0 115.195 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.6 122.73 22.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -75.19 119.58 19.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.19 -54.4 14.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.57 -143.83 15.33 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 104.805 -3.318 . . . . 1.0 104.805 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.48 -154.05 30.69 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.788 1.185 . . . . 1.0 113.0 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -67.83 -57.66 5.91 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 126.59 1.956 . . . . 1.0 110.305 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.03 -33.97 76.57 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.833 0.708 . . . . 1.0 109.091 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -58.01 -59.95 4.48 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.56 -42.8 97.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.946 0.794 . . . . 1.0 111.854 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -54.77 -53.15 58.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.463 1.505 . . . . 1.0 108.075 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.68 88.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.876 0.47 . . . . 1.0 111.04 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -31.39 72.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.475 1.11 . . . . 1.0 110.205 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.64 -52.63 29.17 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.55 -1.344 . . . . 1.0 108.827 168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.21 68.42 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.36 -13.69 59.46 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.654 1.582 . . . . 1.0 112.403 172.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 43.98 17.51 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-O 117.703 -1.61 . . . . 1.0 112.145 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.53 -20.72 6.82 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 120.14 1.97 . . . . 1.0 112.329 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.74 -53.92 9.24 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.092 -1.818 . . . . 1.0 106.092 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -47.49 -51.41 44.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.768 1.227 . . . . 1.0 113.466 -175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.17 -1.6 6.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.176 2.584 . . . . 1.0 116.414 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 mt -111.48 -3.24 15.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.429 1.492 . . . . 1.0 111.552 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -8.14 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.587 0.755 . . . . 1.0 111.789 171.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.161 0 O-C-N 120.477 -1.389 . . . . 1.0 111.079 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.88 79.29 1.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 103.477 -2.786 . . . . 1.0 103.477 171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.36 113.58 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -128.95 146.7 50.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 107.87 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.73 118.94 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.17 136.56 42.85 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -143.38 168.27 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.822 0.849 . . . . 1.0 110.281 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -137.53 174.2 10.85 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 168.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.89 -71.76 0.18 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.038 1.335 . . . . 1.0 108.917 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.1 p -79.21 85.05 5.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -165.85 92.9 0.84 Allowed Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 170.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.91 -30.31 57.67 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.58 1.52 . . . . 1.0 111.785 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.49 -41.16 98.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.691 1.132 . . . . 1.0 111.029 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.5 t -66.01 -37.35 85.69 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.313 -0.851 . . . . 1.0 110.224 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 22.6 m-70 -70.2 -35.6 74.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.839 1.2 . . . . 1.0 111.468 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -51.96 -40.26 60.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.793 1.637 . . . . 1.0 110.031 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -63.2 -26.74 68.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.52 1.304 . . . . 1.0 114.52 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.59 -41.77 45.02 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.335 -0.841 . . . . 1.0 110.259 172.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.79 -30.78 65.95 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.179 0.9 . . . . 1.0 111.248 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD2' ' HE3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -69.41 -63.37 1.08 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 119.328 0.967 . . . . 1.0 110.205 173.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.98 -42.6 90.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.371 -0.347 . . . . 1.0 111.553 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -71.94 -31.77 66.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 117.826 -1.083 . . . . 1.0 111.856 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t -60.4 -37.98 82.56 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 121.129 1.786 . . . . 1.0 109.629 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' A' ' 20' ' ' LEU . 28.0 mttt -88.5 7.18 34.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.431 -0.793 . . . . 1.0 112.066 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.32 42.06 81.67 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.534 2.016 . . . . 1.0 113.505 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.47 147.98 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 118.861 1.331 . . . . 1.0 109.783 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -79.46 153.71 29.43 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.202 1.801 . . . . 1.0 109.228 168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -167.19 147.2 5.39 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.198 0.999 . . . . 1.0 108.714 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -84.1 93.6 8.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.295 2.638 . . . . 1.0 105.407 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.61 136.64 53.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -118.3 87.43 29.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.435 1.494 . . . . 1.0 108.862 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.25 115.98 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.713 2.275 . . . . 1.0 112.136 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pt -98.62 1.9 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.019 1.328 . . . . 1.0 110.07 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -56.9 -37.26 71.15 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.435 -0.791 . . . . 1.0 112.939 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.32 24.28 6.97 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.241 1.877 . . . . 1.0 111.587 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.88 127.36 34.25 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 118.898 1.349 . . . . 1.0 110.019 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.5 -26.56 8.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.73 -49.52 20.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.544 0.611 . . . . 1.0 110.728 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -32.15 70.7 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -55.33 -39.41 69.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.807 1.185 . . . . 1.0 111.201 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.79 -39.49 94.37 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.492 0.587 . . . . 1.0 110.452 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -62.6 -39.54 94.09 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.376 -0.828 . . . . 1.0 110.363 171.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.2 ttp -58.08 -25.77 61.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.879 -1.058 . . . . 1.0 111.539 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.1 mt -57.81 -54.5 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 120.884 1.675 . . . . 1.0 108.099 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.23 -55.11 35.8 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.123 0.569 . . . . 1.0 109.898 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -59.64 -42.69 93.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.965 -0.541 . . . . 1.0 110.904 -171.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -89.16 -26.39 21.32 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 113.236 0.828 . . . . 1.0 113.236 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 57.24 27.49 57.77 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.786 -0.926 . . . . 1.0 110.786 -168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -143.37 -47.16 0.3 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-O 117.61 -1.186 . . . . 1.0 113.991 -168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.31 -19.09 0.46 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.556 2.342 . . . . 1.0 114.548 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 p -81.0 156.0 26.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.452 -0.78 . . . . 1.0 108.928 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.36 160.87 26.84 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.0 110.831 168.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.12 160.66 91.57 Favored 'Cis proline' 0 C--N 1.35 0.608 0 CA-C-N 119.705 0.93 . . . . 1.0 112.401 -2.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -141.16 116.8 10.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 68' ' ' LEU . 4.3 mp -102.33 149.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 104.904 -2.258 . . . . 1.0 104.904 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -136.27 131.96 35.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.6 mt -132.07 120.25 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 105.858 -1.904 . . . . 1.0 105.858 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 50.66 47.38 24.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 123.911 1.815 . . . . 1.0 109.03 -177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.09 -10.24 0.18 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 129.642 3.177 . . . . 1.0 115.065 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -73.95 116.52 14.67 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 120.015 1.28 . . . . 1.0 108.302 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -66.36 127.18 31.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.26 1.024 . . . . 1.0 108.595 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -86.83 -64.79 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.78 -144.62 14.57 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.617 -1.793 . . . . 1.0 108.617 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.45 -164.15 39.3 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.976 1.751 . . . . 1.0 113.272 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.8 t80 -73.45 -54.09 9.1 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.752 -0.852 . . . . 1.0 111.261 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -60.47 -32.38 71.36 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.281 -0.636 . . . . 1.0 109.281 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -60.62 -51.33 69.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 116.521 -1.705 . . . . 1.0 109.39 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HG12 ' A' ' 55' ' ' ILE . 43.4 tp -64.94 -46.02 83.36 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.711 1.596 . . . . 1.0 111.123 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -53.39 -52.88 57.9 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.532 1.533 . . . . 1.0 108.96 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.81 85.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.867 -0.587 . . . . 1.0 110.76 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -31.41 72.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 118.883 0.765 . . . . 1.0 109.978 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.16 -54.3 15.62 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.636 -1.29 . . . . 1.0 109.315 169.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -21.21 63.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -15.08 54.76 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.251 1.42 . . . . 1.0 112.598 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.76 53.24 5.97 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-O 118.976 -0.902 . . . . 1.0 111.574 -169.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.1 -28.96 1.28 Allowed Glycine 0 C--N 1.34 0.778 0 CA-C-N 119.094 1.447 . . . . 1.0 110.144 168.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tt -73.36 -55.52 6.28 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.03 -44.54 85.04 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.846 -1.073 . . . . 1.0 112.032 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.58 -27.99 38.42 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 121.462 1.558 . . . . 1.0 114.156 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -75.02 -9.38 58.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.855 1.661 . . . . 1.0 111.519 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.88 4.67 11.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.74 0.816 . . . . 1.0 109.646 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 tptp . . . . . 0 C--O 1.25 1.11 0 O-C-N 120.471 -1.393 . . . . 1.0 110.55 -176.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.75 74.85 1.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.46 -2.422 . . . . 1.0 104.46 151.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.464 HG21 HD22 ' A' ' 81' ' ' LEU . 47.3 t -98.0 113.22 32.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.446 -1.686 . . . . 1.0 106.446 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.51 147.65 50.38 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.451 -1.315 . . . . 1.0 107.451 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.7 tt -135.8 110.22 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.815 -1.55 . . . . 1.0 106.815 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -73.45 141.14 46.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -142.34 165.82 26.38 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.87 1.268 . . . . 1.0 108.666 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.86 166.82 24.84 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -66.59 167.25 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.342 1.057 . . . . 1.0 109.664 171.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.8 p 56.27 32.84 21.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.307 1.843 . . . . 1.0 111.773 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.64 97.13 8.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.134 0.974 . . . . 1.0 111.231 -168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.49 -35.47 6.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.381 1.388 . . . . 1.0 111.903 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 65' ' ' TYR . 1.8 t80 -53.54 -43.12 68.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.985 1.314 . . . . 1.0 109.434 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.4 t -58.57 -52.83 63.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.584 -0.722 . . . . 1.0 109.739 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -62.68 -34.36 76.96 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.025 0.83 . . . . 1.0 112.017 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.4 mtm-85 -59.08 -48.08 82.91 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.479 1.512 . . . . 1.0 111.39 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.56 -26.68 67.24 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 114.449 1.277 . . . . 1.0 114.449 -168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -76.45 -31.99 58.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.587 1.085 . . . . 1.0 111.57 171.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.36 68.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.752 0.706 . . . . 1.0 109.818 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 20' ' ' LEU . 8.1 tt -63.08 -57.01 12.05 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.315 0.507 . . . . 1.0 110.142 172.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -41.19 77.98 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.851 0.46 . . . . 1.0 110.572 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.1 t -65.85 -44.79 84.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.086 0.955 . . . . 1.0 110.643 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 t -54.53 -45.82 73.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.711 1.141 . . . . 1.0 109.903 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -74.22 2.79 8.31 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.275 1.03 . . . . 1.0 113.402 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 23.1 75.04 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 119.771 1.169 . . . . 1.0 112.582 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.46 158.58 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -116.38 142.2 47.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.766 1.226 . . . . 1.0 108.411 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -158.68 172.46 18.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.914 1.686 . . . . 1.0 108.148 -168.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.26 99.87 7.72 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 127.017 2.127 . . . . 1.0 105.265 -178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.44 139.02 58.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.432 -1.321 . . . . 1.0 107.432 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -126.55 87.57 56.13 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.994 1.318 . . . . 1.0 107.748 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.33 97.36 1.02 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 124.17 3.247 . . . . 1.0 109.332 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.418 HD11 ' CG1' ' A' ' 52' ' ' VAL . 14.4 pt -81.97 25.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 123.257 0.623 . . . . 1.0 112.161 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 12.3 t70 -80.02 144.56 33.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.992 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.5 -46.26 2.78 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.19 1.376 . . . . 1.0 112.917 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 157.67 23.04 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.367 1.867 . . . . 1.0 107.096 170.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.55 -11.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.83 -1.081 . . . . 1.0 111.718 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.78 -57.59 10.34 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 119.871 1.214 . . . . 1.0 109.923 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -70.0 -24.13 63.25 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 118.723 -0.656 . . . . 1.0 111.394 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -65.63 -47.73 74.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.249 0.931 . . . . 1.0 109.402 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -66.13 -35.36 80.29 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.284 0.633 . . . . 1.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -65.53 -40.76 93.29 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.117 -0.989 . . . . 1.0 109.61 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 36.6 ttp -61.19 -41.2 96.39 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.837 -1.165 . . . . 1.0 109.807 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -56.09 -46.65 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 118.18 -0.914 . . . . 1.0 109.024 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -66.82 -35.55 80.33 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.486 1.494 . . . . 1.0 111.393 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.69 -22.47 66.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.242 1.383 . . . . 1.0 112.343 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.5 p -142.36 1.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.865 1.802 . . . . 1.0 115.865 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.33 -2.45 14.81 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.401 -1.222 . . . . 1.0 114.305 -169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -118.18 143.64 46.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.541 2.171 . . . . 1.0 111.354 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.6 p -86.13 -24.21 26.3 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.148 1.379 . . . . 1.0 111.97 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.6 p -74.06 155.63 38.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 120.9 0.381 . . . . 1.0 111.969 -168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -124.68 160.97 51.18 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 125.738 1.615 . . . . 1.0 109.191 171.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.09 169.42 60.63 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.34 0.8 . . . . 1.0 110.583 -6.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -142.74 128.86 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.546 -2.02 . . . . 1.0 105.546 168.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.94 151.33 4.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 104.967 -2.235 . . . . 1.0 104.967 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -134.33 145.05 48.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.936 -1.875 . . . . 1.0 105.936 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 80' ' ' LEU . 90.2 mt -135.57 127.77 46.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 106.305 -1.739 . . . . 1.0 106.305 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 50.19 46.35 24.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.782 1.633 . . . . 1.0 111.032 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.73 10.63 5.23 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 129.748 3.219 . . . . 1.0 114.642 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -95.8 149.93 20.97 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.144 -1.058 . . . . 1.0 108.144 169.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -85.87 138.81 31.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.661 -0.685 . . . . 1.0 109.259 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -79.74 -76.2 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.175 -1.417 . . . . 1.0 107.175 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.74 -141.84 9.61 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 107.021 -2.432 . . . . 1.0 107.021 -168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.41 -179.74 47.41 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 122.399 0.999 . . . . 1.0 112.948 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 13' ' ' TYR . 3.6 t80 -69.16 -40.41 78.18 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.149 1.379 . . . . 1.0 109.927 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.86 -35.4 80.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.446 0.566 . . . . 1.0 109.77 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -64.96 -44.74 88.4 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.55 1.14 . . . . 1.0 109.253 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 tp -62.64 -46.19 89.37 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-O 118.396 -0.812 . . . . 1.0 110.752 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -49.45 -52.86 26.25 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.772 1.169 . . . . 1.0 109.925 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.73 92.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.115 -0.328 . . . . 1.0 110.115 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 tt -59.51 -43.1 93.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.393 1.877 . . . . 1.0 111.381 172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.3 -51.8 11.26 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.2 1.4 . . . . 1.0 111.686 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.37 -21.8 66.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.136 -0.977 . . . . 1.0 112.058 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -82.66 -7.63 59.64 Favored 'General case' 0 C--N 1.334 -0.066 0 O-C-N 121.298 -0.876 . . . . 1.0 112.852 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.36 42.03 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-O 118.52 -1.155 . . . . 1.0 111.658 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.34 -23.74 16.0 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 119.053 1.426 . . . . 1.0 111.923 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.76 -46.77 43.66 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -52.4 -53.89 48.14 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 118.275 -0.869 . . . . 1.0 112.23 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 86.6 Cg_endo -75.73 -20.14 15.73 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.825 1.684 . . . . 1.0 113.057 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 57' ' ' ILE . 13.4 mt -71.97 -26.98 62.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.697 1.59 . . . . 1.0 111.406 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD22 HG21 ' A' ' 3' ' ' VAL . 3.1 tm? -54.68 -55.27 31.52 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.945 1.698 . . . . 1.0 112.536 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 79' ' ' PRO . 15.8 pttp . . . . . 0 C--O 1.248 0.993 0 C-N-CA 127.054 2.142 . . . . 1.0 113.236 -168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 109.027 -0.731 . . . . 1.0 109.027 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.77 65.28 1.31 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.64 120.52 24.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.301 -1.37 . . . . 1.0 107.301 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -131.88 145.19 51.39 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tt -141.66 112.74 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.923 1.289 . . . . 1.0 108.251 -172.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -79.07 133.81 36.77 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.921 -0.561 . . . . 1.0 109.884 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.554 HG21 ' HE3' ' A' ' 18' ' ' LYS . 22.7 p -148.69 160.68 42.94 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.08 0.952 . . . . 1.0 110.627 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -127.41 169.36 13.69 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.649 -0.657 . . . . 1.0 109.864 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.58 163.91 15.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.858 0.863 . . . . 1.0 112.133 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.287 2.0 t 56.64 -8.12 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 131.224 3.809 . . . . 1.0 116.077 175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 74.3 m -78.6 106.28 4.02 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.782 1.633 . . . . 1.0 109.665 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.96 -33.32 63.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.568 1.596 . . . . 1.0 111.214 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.08 -34.9 32.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.175 1.79 . . . . 1.0 111.525 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.67 6.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.419 -0.8 . . . . 1.0 109.427 170.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -62.44 -34.68 77.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 117.542 0.156 . . . . 1.0 111.315 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -50.2 -49.69 51.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.196 1.798 . . . . 1.0 110.808 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 -25.88 67.79 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -73.9 -48.32 31.69 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 117.887 -1.054 . . . . 1.0 110.071 172.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.17 60.81 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 118.168 -0.92 . . . . 1.0 111.021 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.7 -61.9 1.82 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.01 0.924 . . . . 1.0 109.592 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.64 -37.76 79.56 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.749 -0.595 . . . . 1.0 112.025 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -62.28 -42.94 99.78 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.716 1.606 . . . . 1.0 110.042 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 t -55.32 -33.96 63.76 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.721 1.146 . . . . 1.0 111.707 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HE3' ' OD2' ' A' ' 72' ' ' ASP . 4.8 mptp? -92.38 0.93 57.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.221 1.008 . . . . 1.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.72 86.39 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.951 1.263 . . . . 1.0 112.384 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.65 142.99 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.955 1.378 . . . . 1.0 110.236 -173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 m -75.62 159.88 30.72 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 168.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.67 149.58 9.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -93.77 93.97 8.28 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.71 140.02 58.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.8 mt -134.49 93.2 19.07 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.678 1.591 . . . . 1.0 109.059 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.49 140.0 84.98 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.532 3.488 . . . . 1.0 112.486 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.2 11.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.757 1.223 . . . . 1.0 113.384 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.71 124.58 23.68 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 117.694 -1.602 . . . . 1.0 107.255 169.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.55 -23.95 0.49 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.561 1.076 . . . . 1.0 114.745 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -83.46 88.33 6.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 104.946 -2.242 . . . . 1.0 104.946 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.02 48.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.552 -0.749 . . . . 1.0 111.471 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.77 -66.32 0.56 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 1.0 110.928 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -70.73 -16.91 62.81 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 119.114 -0.469 . . . . 1.0 111.272 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.61 -47.78 68.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 118.632 0.651 . . . . 1.0 109.904 168.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -64.51 -31.4 72.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.334 0.97 . . . . 1.0 109.568 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -61.07 -47.2 87.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.26 0.624 . . . . 1.0 110.422 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.9 ttp -57.04 -46.68 82.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.502 1.046 . . . . 1.0 110.482 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 81.0 mt -57.6 -52.42 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -52.95 -54.1 39.85 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.988 0.515 . . . . 1.0 110.684 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -61.72 -23.7 66.31 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.431 -0.795 . . . . 1.0 112.131 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.9 m -103.37 -20.9 13.91 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.458 1.103 . . . . 1.0 113.52 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.18 23.54 62.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.786 0.721 . . . . 1.0 111.407 -168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -144.53 144.1 31.16 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.262 1.825 . . . . 1.0 107.076 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -88.21 -29.02 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.804 0.69 . . . . 1.0 110.585 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -95.2 161.46 14.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.504 0.927 . . . . 1.0 113.504 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 159.96 29.24 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.752 1.621 . . . . 1.0 108.839 168.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.41 163.93 86.9 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 118.632 0.547 . . . . 1.0 110.838 -6.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -138.04 139.61 39.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 105.272 -2.122 . . . . 1.0 105.272 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.54 150.83 27.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.056 -1.831 . . . . 1.0 106.056 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -131.8 144.5 50.97 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.222 2.209 . . . . 1.0 105.436 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mt -137.16 130.38 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 104.956 -2.239 . . . . 1.0 104.956 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 53.36 38.27 27.45 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.774 1.23 . . . . 1.0 109.349 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.25 -4.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 130.759 3.624 . . . . 1.0 115.547 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -74.06 128.48 35.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.861 -1.533 . . . . 1.0 106.861 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -71.6 156.31 39.55 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.709 -0.619 . . . . 1.0 110.828 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.33 -72.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.047 0.939 . . . . 1.0 109.161 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.37 -47.88 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.265 -1.134 . . . . 1.0 110.265 -169.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.86 -165.79 39.17 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.94 -59.37 2.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.13 1.372 . . . . 1.0 111.321 -174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -30.4 70.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.038 0.836 . . . . 1.0 109.962 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -61.12 -50.75 71.94 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.176 -0.676 . . . . 1.0 109.176 172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.25 -46.71 85.6 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 119.802 1.183 . . . . 1.0 111.904 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -48.1 -53.26 17.15 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.627 1.571 . . . . 1.0 110.738 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.14 96.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.329 1.052 . . . . 1.0 110.398 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.14 -34.51 75.12 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.294 1.438 . . . . 1.0 111.216 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' OD2' ' HE3' ' A' ' 24' ' ' LYS . 21.9 t70 -69.7 -53.68 17.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.687 -1.258 . . . . 1.0 109.919 170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.91 -25.73 66.96 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.269 1.028 . . . . 1.0 112.966 -173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HE ' ' HA3' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -78.54 -9.01 59.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.186 0.994 . . . . 1.0 113.461 174.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.56 22.95 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA3' ' HE ' ' A' ' 74' ' ' ARG . . . -114.04 -31.17 2.33 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.244 1.402 . . . . 1.0 112.499 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.36 -45.48 54.77 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.307 -2.109 . . . . 1.0 105.307 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -56.42 -50.74 85.94 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.283 -0.865 . . . . 1.0 112.207 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.38 -28.55 39.16 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.027 1.818 . . . . 1.0 113.86 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.21 -22.53 66.9 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.676 1.125 . . . . 1.0 111.042 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.55 35.79 0.41 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.545 1.538 . . . . 1.0 110.217 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.813 0 C-N-CA 124.985 1.314 . . . . 1.0 107.836 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 120.332 0.11 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -155.09 84.08 1.07 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.447 1.499 . . . . 1.0 107.087 167.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.6 t -88.44 120.71 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 -173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 150.93 48.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' A' ' 18' ' ' LYS . 12.0 tt -139.67 112.02 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -73.43 143.43 46.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.474 -0.935 . . . . 1.0 108.474 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -147.95 161.42 41.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.621 1.568 . . . . 1.0 107.671 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -146.4 149.19 33.25 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.417 -2.068 . . . . 1.0 105.417 172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.04 158.86 10.27 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.803 1.641 . . . . 1.0 110.999 170.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.315 3.6 t 49.06 52.37 14.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.676 1.59 . . . . 1.0 110.79 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.1 t -147.57 110.68 3.91 Favored Pre-proline 0 N--CA 1.45 -0.444 0 O-C-N 121.54 -0.725 . . . . 1.0 110.826 171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.84 -45.33 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.341 1.36 . . . . 1.0 111.116 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CD2' ' HA1' ' A' ' 83' ' ' GSH . 12.3 t80 -49.01 -40.83 32.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.403 2.281 . . . . 1.0 111.548 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 t -56.94 -47.75 79.91 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.685 1.594 . . . . 1.0 111.921 172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -83.41 -28.27 28.98 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.434 -0.791 . . . . 1.0 112.018 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -57.51 -42.49 82.91 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.004 1.321 . . . . 1.0 110.283 169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -58.52 -26.09 63.12 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.952 0.723 . . . . 1.0 112.952 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' HG21 ' A' ' 5' ' ' ILE . 1.9 mptm? -76.32 -29.79 57.45 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 116.508 -1.71 . . . . 1.0 113.525 174.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.55 78.03 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 121.413 1.915 . . . . 1.0 109.569 171.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.95 -63.08 1.17 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -66.43 -28.82 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 118.876 -0.583 . . . . 1.0 111.616 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 t -75.35 -36.42 60.98 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 117.692 -1.147 . . . . 1.0 110.695 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.3 t -56.75 -23.17 40.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.495 1.498 . . . . 1.0 110.534 169.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -110.26 11.03 23.6 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.833 1.653 . . . . 1.0 112.037 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 50.41 35.58 28.71 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 124.407 1.003 . . . . 1.0 114.044 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.4 t -83.62 145.01 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 118.971 1.385 . . . . 1.0 107.603 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -96.09 54.93 1.5 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.212 1.805 . . . . 1.0 109.002 -168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -74.64 171.98 12.9 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.637 0.775 . . . . 1.0 110.517 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 106.7 9.11 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.434 2.294 . . . . 1.0 105.724 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -53.41 149.84 7.19 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 1.0 110.308 168.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.5 mt -139.68 87.72 12.84 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.955 2.102 . . . . 1.0 109.05 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.19 140.65 95.85 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.412 3.408 . . . . 1.0 111.589 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 -3.87 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.739 1.216 . . . . 1.0 113.458 170.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.36 132.66 49.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.522 -1.288 . . . . 1.0 107.522 168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -39.86 0.51 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.285 1.421 . . . . 1.0 113.103 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.691 HD21 ' HB3' ' A' ' 39' ' ' LYS . 3.7 t30 -83.63 67.99 9.66 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.17 1.788 . . . . 1.0 108.042 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.3 -21.23 66.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.218 -0.901 . . . . 1.0 111.55 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.17 -72.42 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.97 1.308 . . . . 1.0 110.009 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 36' ' ' ASN . 14.9 ttpt -68.4 -13.02 61.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.772 0.714 . . . . 1.0 111.073 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -61.22 -43.19 99.28 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 168.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.3 -27.42 64.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.497 1.044 . . . . 1.0 112.511 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.22 -48.92 76.25 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.196 -1.039 . . . . 1.0 108.196 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -54.56 -40.39 68.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.05 0.94 . . . . 1.0 111.733 174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.8 mt -58.94 -55.95 20.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 123.92 0.888 . . . . 1.0 109.191 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -56.68 -42.9 79.86 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.402 0.546 . . . . 1.0 109.634 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.43 -12.4 60.16 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.925 1.69 . . . . 1.0 114.206 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -144.44 -9.4 0.65 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.772 2.508 . . . . 1.0 117.772 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.21 18.69 69.53 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 119.147 0.885 . . . . 1.0 112.724 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -142.82 149.82 39.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 125.818 1.647 . . . . 1.0 106.834 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.258 9.6 t -107.9 -0.09 21.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.793 0.724 . . . . 1.0 111.816 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 p -111.92 143.86 42.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.997 0.817 . . . . 1.0 110.521 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -89.57 164.03 30.96 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 123.905 0.882 . . . . 1.0 112.39 -172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -86.72 169.61 42.23 Favored 'Cis proline' 0 N--CA 1.457 -0.655 0 CA-C-N 118.875 0.634 . . . . 1.0 111.148 -11.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -138.22 128.52 26.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 168.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -98.24 150.24 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 104.911 -2.255 . . . . 1.0 104.911 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.09 139.74 46.15 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.3 mt -131.62 110.13 16.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.988 -2.597 . . . . 1.0 103.988 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 47.74 48.18 17.56 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.414 1.102 . . . . 1.0 111.873 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.55 4.25 1.73 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.264 2.626 . . . . 1.0 114.94 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.62 104.38 4.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.415 -2.439 . . . . 1.0 104.415 168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -73.99 117.85 16.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.53 -1.285 . . . . 1.0 107.53 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.73 -40.97 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 118.527 0.603 . . . . 1.0 109.877 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.29 -127.55 4.2 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 106.819 -2.512 . . . . 1.0 106.819 -170.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 -149.32 21.43 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.456 1.979 . . . . 1.0 110.213 168.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 44.3 t80 -86.35 -45.82 10.86 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.939 0.895 . . . . 1.0 110.522 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.47 -32.15 69.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 118.968 0.804 . . . . 1.0 109.343 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.97 -53.42 57.44 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.381 0.672 . . . . 1.0 109.526 172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.7 -49.65 76.64 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 123.242 0.617 . . . . 1.0 110.565 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -48.61 -53.39 18.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.658 1.583 . . . . 1.0 110.195 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.59 94.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.208 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.44 -37.57 87.31 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.651 0.739 . . . . 1.0 110.005 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.72 -57.64 8.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.431 1.092 . . . . 1.0 109.331 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.31 -17.67 63.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.718 1.377 . . . . 1.0 114.718 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -78.64 -9.68 59.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.196 1.362 . . . . 1.0 110.966 169.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 10.9 85.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 126.098 1.809 . . . . 1.0 112.329 -171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.07 -33.2 27.11 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.192 1.996 . . . . 1.0 109.831 -171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.5 -44.6 57.43 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 -168.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.19 -52.94 54.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 113.942 1.089 . . . . 1.0 113.942 -170.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.66 -19.89 9.65 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.182 1.922 . . . . 1.0 113.136 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.25 -10.0 59.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.778 1.172 . . . . 1.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -8.74 49.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.659 0.784 . . . . 1.0 110.836 172.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mttm . . . . . 0 C--O 1.249 1.045 0 N-CA-C 106.637 -1.616 . . . . 1.0 106.637 169.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . 0.583 ' HA1' ' CD2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.336 0 CA-C-O 120.555 0.216 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.52 72.04 0.96 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.42 2.288 . . . . 1.0 105.918 158.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.11 136.68 24.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -135.03 144.14 47.14 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.886 1.674 . . . . 1.0 106.735 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 tt -139.25 105.51 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.945 -1.872 . . . . 1.0 105.945 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.67 118.92 23.2 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 p -138.4 -177.58 4.91 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.857 0.753 . . . . 1.0 112.217 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -135.7 160.66 37.84 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -49.81 -62.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.894 2.077 . . . . 1.0 111.223 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.2 p -82.8 62.0 6.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.621 1.169 . . . . 1.0 111.216 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 4.3 t -158.62 98.04 1.73 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 121.508 -0.745 . . . . 1.0 111.948 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.38 -26.74 47.95 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.429 2.086 . . . . 1.0 114.504 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -55.98 -41.34 74.64 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.046 1.294 . . . . 1.0 109.732 171.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -61.53 -52.49 64.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.976 1.311 . . . . 1.0 111.035 172.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -55.0 -43.14 73.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.245 0.929 . . . . 1.0 110.88 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -46.91 -54.15 10.66 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.036 1.334 . . . . 1.0 111.53 169.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -64.39 -26.69 68.57 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 115.041 1.497 . . . . 1.0 115.041 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 -43.31 43.14 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 119.112 0.869 . . . . 1.0 110.801 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.29 67.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.379 -0.819 . . . . 1.0 111.611 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -56.13 10.27 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.177 0.899 . . . . 1.0 108.733 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -56.18 -44.31 79.26 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.667 -0.645 . . . . 1.0 110.653 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 m -64.03 -35.3 80.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.473 0.916 . . . . 1.0 113.473 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.2 t -60.78 -30.89 70.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.31 1.414 . . . . 1.0 110.494 171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.71 2.9 56.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.063 1.345 . . . . 1.0 111.262 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.03 17.3 60.9 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.781 1.658 . . . . 1.0 113.228 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.43 141.04 15.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 119.888 1.844 . . . . 1.0 107.749 -170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -83.55 156.54 22.73 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 168.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -155.93 168.64 26.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.172 0.989 . . . . 1.0 109.885 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -113.45 101.48 9.41 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 102.718 -3.067 . . . . 1.0 102.718 169.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 136.9 40.17 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.676 -1.972 . . . . 1.0 105.676 168.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.53 84.25 35.85 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 107.695 -1.224 . . . . 1.0 107.695 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -49.28 115.39 1.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.076 2.517 . . . . 1.0 111.034 169.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' HA ' HD21 ' A' ' 36' ' ' ASN 0.277 1.1 pt -94.51 2.67 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 124.824 1.25 . . . . 1.0 112.248 174.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.98 156.06 25.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 168.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.61 -34.52 1.38 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.237 1.399 . . . . 1.0 114.448 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.525 HD21 ' HA ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -118.26 98.38 6.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.505 1.653 . . . . 1.0 107.867 -172.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.76 68.11 Favored 'General case' 0 C--O 1.224 -0.252 0 O-C-N 121.442 -0.786 . . . . 1.0 111.812 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 -63.72 1.2 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.295 1.038 . . . . 1.0 111.706 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -64.32 -25.55 68.09 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.949 -1.094 . . . . 1.0 111.758 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 33' ' ' ILE . 16.7 ttp-105 -64.72 -45.14 87.82 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 121.258 -0.901 . . . . 1.0 109.972 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.25 -31.65 70.33 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.382 1.073 . . . . 1.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -55.27 -50.85 68.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.792 0.724 . . . . 1.0 109.491 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ttp -56.51 -40.66 75.39 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.253 -0.403 . . . . 1.0 111.226 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.49 -56.92 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.053 1.341 . . . . 1.0 108.156 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -64.9 -44.49 89.44 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.256 -0.902 . . . . 1.0 111.342 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -58.8 -34.99 72.12 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.846 0.748 . . . . 1.0 111.855 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.8 p -93.31 -20.16 20.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.542 0.737 . . . . 1.0 112.988 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.47 32.46 77.76 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.796 -1.321 . . . . 1.0 109.796 -169.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -132.06 -174.49 3.45 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.003 2.121 . . . . 1.0 107.347 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -117.28 -35.81 3.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -168.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -139.17 171.02 14.91 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.838 1.199 . . . . 1.0 112.298 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 33' ' ' ILE . 1.3 m -83.98 169.52 16.81 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.184 0.994 . . . . 1.0 109.949 -173.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 93.3 Cg_endo -70.92 158.57 94.38 Favored 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 120.77 1.311 . . . . 1.0 109.017 -11.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -138.83 132.69 30.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.797 -2.298 . . . . 1.0 104.797 169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.6 147.95 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.089 -2.189 . . . . 1.0 105.089 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -138.3 137.08 37.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.135 -2.172 . . . . 1.0 105.135 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -135.2 123.61 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 106.404 -1.702 . . . . 1.0 106.404 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.66 24.63 5.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.964 1.306 . . . . 1.0 113.305 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 100.38 -18.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 132.29 4.236 . . . . 1.0 112.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -75.55 106.58 7.18 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.974 -1.121 . . . . 1.0 107.974 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -59.72 128.71 38.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 168.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.4 mm -83.91 -50.89 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.83 -149.57 19.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 107.025 -2.43 . . . . 1.0 107.025 -168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.66 -156.23 11.16 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.362 1.458 . . . . 1.0 112.326 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.0 t80 -84.11 -49.47 8.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.418 0.687 . . . . 1.0 112.407 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.59 -27.42 69.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.594 0.712 . . . . 1.0 109.314 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.05 -56.67 14.98 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.274 -1.38 . . . . 1.0 107.274 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -59.86 -46.93 87.75 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 118.78 0.718 . . . . 1.0 112.378 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -52.02 -53.15 45.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.691 1.997 . . . . 1.0 108.998 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.4 96.11 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.945 -1.097 . . . . 1.0 111.367 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.17 -29.89 70.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.886 0.874 . . . . 1.0 110.015 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.27 -56.51 8.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 120.602 -1.311 . . . . 1.0 109.62 168.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.8 67.43 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.449 0.907 . . . . 1.0 113.449 -169.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -15.62 56.44 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.006 1.322 . . . . 1.0 112.887 171.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.04 46.35 8.35 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 125.089 1.328 . . . . 1.0 111.634 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.22 -23.56 5.73 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.69 1.745 . . . . 1.0 112.139 169.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -46.83 47.58 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 177.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -55.32 -49.34 92.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.997 -1.002 . . . . 1.0 112.471 -175.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.6 -25.33 15.06 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.733 1.622 . . . . 1.0 114.19 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mt -64.62 -27.92 69.27 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.575 1.534 . . . . 1.0 110.876 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.42 -40.49 62.24 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.385 0.674 . . . . 1.0 110.009 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 C-N-CA 127.259 2.224 . . . . 1.0 111.93 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.89 58.31 0.77 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 104.575 -2.379 . . . . 1.0 104.575 -164.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.23 71.42 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 128.495 2.718 . . . . 1.0 106.731 -169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -93.66 141.88 27.98 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.665 -1.272 . . . . 1.0 109.006 -169.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -132.32 114.35 23.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.02 1.328 . . . . 1.0 108.426 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.73 134.44 43.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.236 0.615 . . . . 1.0 109.404 173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -150.35 161.43 42.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.377 1.071 . . . . 1.0 110.166 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -130.95 165.97 21.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.054 -2.202 . . . . 1.0 105.054 167.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.16 -65.35 0.62 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.734 1.213 . . . . 1.0 111.036 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -85.64 82.67 8.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.043 0.937 . . . . 1.0 108.659 -171.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -158.5 114.22 1.7 Allowed Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 118.945 -0.55 . . . . 1.0 109.984 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.3 -47.34 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.595 1.53 . . . . 1.0 111.637 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -52.94 -33.68 51.93 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.097 1.759 . . . . 1.0 111.593 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 t -68.39 -50.35 53.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.549 1.14 . . . . 1.0 110.843 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -72.83 -27.85 62.2 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.811 1.187 . . . . 1.0 111.279 -174.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -55.35 -39.93 70.64 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.433 1.093 . . . . 1.0 111.171 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.65 -26.01 63.34 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -76.41 -42.5 44.06 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 117.997 -1.001 . . . . 1.0 110.091 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -24.37 64.77 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.889 1.222 . . . . 1.0 110.943 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.58 -66.76 0.7 Allowed 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 118.593 0.633 . . . . 1.0 109.652 169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 26' ' ' VAL . 50.1 mt -61.07 -39.17 88.88 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.773 -0.579 . . . . 1.0 111.023 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -32.68 68.6 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.573 1.549 . . . . 1.0 111.006 175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 t -58.57 -39.78 81.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 121.538 1.972 . . . . 1.0 108.726 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -80.55 -0.06 36.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.807 1.243 . . . . 1.0 112.946 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.88 89.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.416 1.484 . . . . 1.0 114.129 172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 m -90.95 148.72 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.858 1.329 . . . . 1.0 111.203 -173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.3 m -85.6 91.52 8.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.37 154.08 18.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.86 101.47 10.9 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -62.98 142.2 58.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.074 -0.966 . . . . 1.0 109.882 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -134.49 95.84 15.8 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 126.822 2.049 . . . . 1.0 107.211 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.0 150.64 88.06 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.708 2.938 . . . . 1.0 110.56 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.75 -8.06 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.32 1.448 . . . . 1.0 112.43 170.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.09 150.56 37.24 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.986 1.721 . . . . 1.0 107.117 168.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.64 80.75 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.859 -0.967 . . . . 1.0 113.411 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.81 116.11 5.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.525 1.662 . . . . 1.0 110.545 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.1 -26.45 31.04 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.29 -0.881 . . . . 1.0 111.87 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.5 -61.95 1.72 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.652 0.781 . . . . 1.0 110.841 -168.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -68.15 -16.14 63.87 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.598 -0.689 . . . . 1.0 112.324 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.12 -51.35 47.23 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.223 -1.399 . . . . 1.0 107.223 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.39 -26.48 68.5 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.699 1.136 . . . . 1.0 112.81 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -62.7 -59.58 4.7 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.904 -1.147 . . . . 1.0 107.904 168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -49.89 -40.85 44.22 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.225 1.41 . . . . 1.0 111.801 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.88 -52.05 65.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.753 1.221 . . . . 1.0 109.127 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -70.81 -17.86 62.75 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.451 -0.781 . . . . 1.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -83.38 -27.2 29.8 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.298 -0.876 . . . . 1.0 112.493 173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.5 m -111.39 -24.11 10.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.697 1.369 . . . . 1.0 114.697 -168.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.41 -9.72 13.6 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 118.425 0.557 . . . . 1.0 112.314 -168.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -116.19 158.85 22.65 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 127.092 2.157 . . . . 1.0 107.962 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 -13.99 9.06 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.235 1.014 . . . . 1.0 109.364 -173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.5 p -74.75 -177.5 3.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.944 1.697 . . . . 1.0 111.129 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.43 163.31 50.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.776 2.03 . . . . 1.0 110.313 169.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 162.21 91.02 Favored 'Cis proline' 0 N--CA 1.456 -0.707 0 C-N-CA 125.04 -0.817 . . . . 1.0 110.697 -10.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -125.99 130.09 50.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 103.799 -2.667 . . . . 1.0 103.799 168.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.5 mt -121.09 145.38 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.071 -2.196 . . . . 1.0 105.071 -173.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -131.47 145.41 51.76 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.105 -1.813 . . . . 1.0 106.105 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.49 112.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 104.211 -2.515 . . . . 1.0 104.211 169.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 53.81 42.57 31.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.675 1.226 . . . . 1.0 110.08 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.41 -3.35 1.62 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 129.465 3.106 . . . . 1.0 115.063 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.443 HE22 HD22 ' A' ' 80' ' ' LEU . 27.3 mt-30 -73.82 112.65 10.14 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -74.37 123.09 23.98 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mm -77.33 -41.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.857 0.837 . . . . 1.0 108.866 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.3 -119.95 3.4 Favored Glycine 0 N--CA 1.442 -0.915 1 N-CA-C 102.55 -4.22 . . . . 1.0 102.55 -168.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.5 -147.5 6.82 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 126.143 1.83 . . . . 1.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -69.99 -52.8 21.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.65 1.18 . . . . 1.0 110.248 -171.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.7 -35.1 79.94 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.7 -52.36 63.59 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.52 -45.61 91.23 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.698 -0.668 . . . . 1.0 112.341 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -51.91 -53.66 38.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.079 0.854 . . . . 1.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.08 90.64 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.3 -0.863 . . . . 1.0 109.831 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.94 -38.46 88.54 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.547 1.539 . . . . 1.0 112.01 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.25 -57.73 9.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.111 -1.07 . . . . 1.0 108.111 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.2 -16.13 63.2 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.317 1.447 . . . . 1.0 113.849 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -75.5 -10.11 59.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.776 0.83 . . . . 1.0 111.633 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 24.49 56.12 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.687 1.136 . . . . 1.0 110.888 -169.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.05 -23.4 7.4 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.166 1.483 . . . . 1.0 112.893 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -47.55 41.29 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -44.09 -53.76 12.82 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.48 -1.248 . . . . 1.0 113.874 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.0 -19.08 20.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.901 2.401 . . . . 1.0 114.261 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HE22 ' A' ' 60' ' ' GLN . 79.0 mt -83.55 -14.1 52.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.991 0.814 . . . . 1.0 110.509 173.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.61 18.25 0.34 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.355 1.462 . . . . 1.0 110.026 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 N-CA-C 104.411 -2.44 . . . . 1.0 104.411 170.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -159.27 83.29 0.77 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.925 0.89 . . . . 1.0 109.977 178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.33 120.1 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.824 -1.176 . . . . 1.0 107.824 171.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.07 154.35 31.14 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.669 1.188 . . . . 1.0 108.867 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -144.16 119.73 4.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 124.442 1.097 . . . . 1.0 108.467 171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -74.08 132.67 42.52 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -132.1 166.08 22.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.079 1.352 . . . . 1.0 108.993 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 11' ' ' CYS . 13.3 pttp -145.51 151.48 38.23 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.492 -1.299 . . . . 1.0 107.492 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.55 161.02 23.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.346 1.059 . . . . 1.0 110.451 168.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.294 14.7 t 47.08 60.21 3.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.443 2.697 . . . . 1.0 110.537 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' HE3' ' A' ' 8' ' ' LYS . 28.4 t -161.28 104.37 1.23 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.244 1.418 . . . . 1.0 108.038 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.55 -35.62 22.25 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 CA-C-N 120.135 1.084 . . . . 1.0 111.169 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' CE1' ' HA1' ' A' ' 83' ' ' GSH . 15.8 t80 -58.68 -33.76 70.51 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.539 1.136 . . . . 1.0 111.589 177.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -62.96 -53.03 60.34 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 27.6 m-70 -57.1 -47.4 81.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.705 0.632 . . . . 1.0 112.705 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -48.58 -42.37 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.845 2.058 . . . . 1.0 111.28 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -74.88 -26.71 59.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.04 -43.24 65.26 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.868 -1.16 . . . . 1.0 107.868 169.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -32.99 64.9 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.67 -0.681 . . . . 1.0 111.362 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -62.71 1.39 Allowed 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.73 -28.28 63.74 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.079 0.77 . . . . 1.0 113.079 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 t -78.56 -41.94 30.6 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.746 1.618 . . . . 1.0 110.459 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.5 t -60.99 -33.78 73.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 1.0 110.161 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -79.42 -5.64 55.11 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.213 1.805 . . . . 1.0 111.72 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.03 61.56 4.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 125.735 1.636 . . . . 1.0 111.318 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 t -113.49 150.46 15.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.013 0.925 . . . . 1.0 108.587 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.5 m -77.44 112.79 14.56 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.09 -1.448 . . . . 1.0 107.09 168.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -131.51 139.44 49.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.651 0.739 . . . . 1.0 109.931 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -89.19 98.64 11.88 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 128.687 2.795 . . . . 1.0 105.064 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -68.2 144.22 55.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.397 168.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.83 100.53 19.17 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 126.967 2.107 . . . . 1.0 108.532 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.94 134.51 46.79 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 N-CA-C 109.067 -1.166 . . . . 1.0 109.067 169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 pt -115.16 4.34 7.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.999 1.32 . . . . 1.0 110.775 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.62 161.53 26.89 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 167.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.28 12.82 63.96 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.78 -1.011 . . . . 1.0 113.883 -170.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -151.48 160.85 43.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.981 1.712 . . . . 1.0 111.24 -169.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 -26.08 1.55 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.733 0.813 . . . . 1.0 112.513 168.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.51 -58.92 5.07 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.105 -0.997 . . . . 1.0 111.286 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -66.89 -33.17 75.0 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.282 0.633 . . . . 1.0 111.604 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.537 ' H ' HD21 ' A' ' 36' ' ' ASN . 7.0 tpt180 -51.74 -52.61 47.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 119.117 -0.468 . . . . 1.0 109.744 169.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.72 -36.52 78.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.226 0.466 . . . . 1.0 111.317 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -59.8 -38.34 81.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.313 0.645 . . . . 1.0 110.805 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.6 ttp -60.53 -39.34 87.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.527 -1.225 . . . . 1.0 111.563 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 50' ' ' THR . 18.5 mm -57.94 -55.47 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 120.485 1.493 . . . . 1.0 107.233 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -69.37 -17.22 63.66 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.318 0.5 OUTLIER -92.89 -5.14 51.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.558 1.526 . . . . 1.0 112.739 171.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 41.0 p -112.92 -60.03 1.94 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 120.155 1.343 . . . . 1.0 111.181 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.66 -3.43 24.64 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.044 1.307 . . . . 1.0 113.223 -169.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.478 ' HB2' HE22 ' A' ' 54' ' ' GLN . 71.4 mtt180 -140.63 150.16 43.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.274 2.037 . . . . 1.0 108.709 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.651 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.4 m -83.65 -27.26 29.23 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.474 -175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -73.88 144.1 45.55 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.356 -0.84 . . . . 1.0 112.575 -172.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.99 161.61 25.72 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.436 1.494 . . . . 1.0 108.885 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.92 163.61 86.7 Favored 'Cis proline' 0 N--CA 1.46 -0.464 0 N-CA-C 110.266 -0.705 . . . . 1.0 110.266 -9.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 HE22 ' HB2' ' A' ' 49' ' ' ARG . 15.7 mm-40 -130.79 121.46 25.4 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 105.664 -1.976 . . . . 1.0 105.664 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.61 144.91 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 105.209 -2.145 . . . . 1.0 105.209 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.4 140.3 49.62 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 106.495 -1.668 . . . . 1.0 106.495 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.91 120.08 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 104.918 -2.253 . . . . 1.0 104.918 175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 47.69 44.65 17.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.904 1.335 . . . . 1.0 111.071 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 65.18 -1.79 0.85 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.964 2.906 . . . . 1.0 115.799 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.57 138.38 35.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 121.407 1.912 . . . . 1.0 108.27 168.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 13.8 t-80 -79.71 142.38 35.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.834 -0.802 . . . . 1.0 108.834 177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mm -79.94 -58.95 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.392 0.542 . . . . 1.0 109.864 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.45 -53.72 0.47 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.295 -0.722 . . . . 1.0 111.295 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.92 -166.44 19.67 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 127.054 2.264 . . . . 1.0 109.7 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 6.8 t80 -83.56 -52.43 6.48 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 126.519 1.927 . . . . 1.0 111.162 169.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.92 -26.75 66.19 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.014 -0.735 . . . . 1.0 109.014 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.14 -50.48 54.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.345 1.058 . . . . 1.0 110.32 170.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 tp -62.49 -47.8 82.37 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 119.848 1.204 . . . . 1.0 111.356 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -52.01 -53.52 40.84 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 118.676 0.671 . . . . 1.0 110.356 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.44 87.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.914 0.324 . . . . 1.0 110.948 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -37.39 87.01 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.12 -50.48 63.88 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.458 -1.401 . . . . 1.0 110.535 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.33 -26.42 67.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 113.614 0.968 . . . . 1.0 113.614 -169.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.91 -7.51 56.84 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.239 1.416 . . . . 1.0 112.968 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.45 46.42 25.88 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 117.569 -1.684 . . . . 1.0 110.391 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.82 -29.63 4.3 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 117.529 -1.706 . . . . 1.0 110.311 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.35 -50.99 19.04 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.277 2.038 . . . . 1.0 105.972 176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -51.9 45.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.532 1.133 . . . . 1.0 113.929 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -71.04 -35.37 9.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 CA-C-N 121.194 1.462 . . . . 1.0 111.981 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.3 mt -75.39 -12.97 60.37 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.714 0.688 . . . . 1.0 111.705 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.03 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.36 1.464 . . . . 1.0 110.078 168.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 N-CA-C 107.388 -1.338 . . . . 1.0 107.388 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . 0.428 ' HA1' ' CE1' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.162 0.506 . . . . 1.0 109.637 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.95 72.12 1.08 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.191 1.796 . . . . 1.0 106.535 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.0 t -73.68 111.9 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -100.95 146.77 26.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 tt -144.89 107.75 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.231 1.012 . . . . 1.0 108.778 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -74.86 137.78 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.612 0.765 . . . . 1.0 110.885 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.3 p -144.88 172.5 12.95 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 1.0 110.309 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -143.26 130.18 20.54 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -66.54 83.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t 166.83 -45.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 128.596 2.758 . . . . 1.0 106.698 170.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.94 110.45 3.83 Favored Pre-proline 0 N--CA 1.445 -0.72 0 C-N-CA 124.008 0.923 . . . . 1.0 109.941 -168.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 -28.67 18.09 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.791 1.66 . . . . 1.0 111.151 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -55.81 -43.98 77.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.306 1.042 . . . . 1.0 110.325 171.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -48.74 79.73 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.853 1.261 . . . . 1.0 112.34 170.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m-70 -65.88 -34.27 77.75 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.798 0.666 . . . . 1.0 112.798 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -50.21 54.2 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.183 1.793 . . . . 1.0 112.419 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 -26.13 62.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.62 1.341 . . . . 1.0 114.62 -174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -75.96 -30.25 58.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 118.217 -0.897 . . . . 1.0 112.235 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.41 83.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.979 1.263 . . . . 1.0 109.869 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.66 -56.03 14.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.495 0.589 . . . . 1.0 110.131 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 mt -65.86 -34.95 79.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.678 0.621 . . . . 1.0 112.678 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 t -76.04 -23.02 55.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.454 -0.784 . . . . 1.0 110.948 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.41 -40.98 75.57 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.91 1.232 . . . . 1.0 108.834 168.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -45.57 52.97 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.88 0.764 . . . . 1.0 109.506 171.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.55 75.82 0.86 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 106.871 -2.492 . . . . 1.0 106.871 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.8 t -106.89 153.19 8.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -80.37 75.52 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 168.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -75.08 172.33 12.54 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.815 0.846 . . . . 1.0 109.678 169.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -127.97 106.16 8.9 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 102.974 -2.973 . . . . 1.0 102.974 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -75.9 146.59 39.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -124.61 95.94 41.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 125.431 1.493 . . . . 1.0 107.876 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -58.68 136.84 76.62 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 N-CA-C 108.469 -1.397 . . . . 1.0 108.469 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.485 HD11 ' CG1' ' A' ' 52' ' ' VAL . 6.7 pt -132.28 58.69 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.478 1.911 . . . . 1.0 108.389 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -116.62 118.13 31.74 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 112.193 -2.276 . . . . 1.0 108.478 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.67 -35.57 1.61 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.33 1.443 . . . . 1.0 113.859 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -83.3 121.8 27.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.366 1.066 . . . . 1.0 108.825 175.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -24.62 21.86 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.992 0.917 . . . . 1.0 111.887 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -61.88 2.25 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.845 0.858 . . . . 1.0 109.478 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HB3' HD21 ' A' ' 36' ' ' ASN . 8.2 ttpt -67.16 -27.09 67.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.406 1.083 . . . . 1.0 110.706 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HE ' ' HB ' ' A' ' 33' ' ' ILE . 10.5 tpp85 -63.19 -49.63 73.52 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 108.477 -0.935 . . . . 1.0 108.477 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -70.56 -22.89 62.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.675 . . . . 1.0 111.468 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.14 -61.7 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.787 -1.56 . . . . 1.0 106.787 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.2 ttp -48.16 -42.63 30.13 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.964 0.905 . . . . 1.0 111.566 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -54.98 -55.65 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 118.327 -0.844 . . . . 1.0 109.207 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.87 -16.86 61.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.825 1.648 . . . . 1.0 113.569 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -70.9 -20.36 62.51 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 120.728 1.604 . . . . 1.0 111.599 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 65.6 p -137.19 -20.64 1.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 117.851 2.538 . . . . 1.0 117.851 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.1 15.31 81.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-N 119.185 0.902 . . . . 1.0 111.145 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -139.4 149.56 44.24 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 119.562 1.681 . . . . 1.0 110.189 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.6 p -105.95 -14.72 15.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.859 1.264 . . . . 1.0 112.074 -169.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 p -91.2 161.26 15.14 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.276 1.03 . . . . 1.0 111.785 -169.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 33' ' ' ILE . 22.6 m -108.07 159.24 31.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.039 1.336 . . . . 1.0 110.964 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.93 163.79 79.4 Favored 'Cis proline' 0 N--CA 1.45 -1.054 0 N-CA-C 109.777 -0.893 . . . . 1.0 109.777 -11.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -143.32 141.46 30.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.239 -1.763 . . . . 1.0 106.239 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.73 148.35 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 -171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -139.67 113.78 8.9 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.9 mt -107.12 110.43 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 105.805 -1.924 . . . . 1.0 105.805 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 52.07 40.33 28.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.24 1.019 . . . . 1.0 109.853 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.17 42.61 21.84 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.653 1.981 . . . . 1.0 112.647 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -114.98 103.68 11.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.321 1.849 . . . . 1.0 106.498 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -60.71 122.22 14.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.156 0.982 . . . . 1.0 111.021 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.97 -48.26 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.624 0.77 . . . . 1.0 110.913 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.99 -134.16 8.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 106.673 -2.571 . . . . 1.0 106.673 -168.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.67 -163.1 36.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.831 1.681 . . . . 1.0 113.885 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.39 -56.99 4.07 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.618 1.167 . . . . 1.0 110.776 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -63.91 -25.56 68.2 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.85 -63.73 1.2 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 168.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.34 -40.24 81.62 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.325 0.966 . . . . 1.0 111.507 -174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -55.1 -53.48 55.31 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.239 1.016 . . . . 1.0 108.888 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.11 -34.82 78.92 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.568 -0.708 . . . . 1.0 111.063 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -38.51 87.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.021 2.128 . . . . 1.0 109.98 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -55.95 27.6 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.641 1.177 . . . . 1.0 108.19 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.71 -26.34 67.72 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.758 1.392 . . . . 1.0 114.758 -169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -14.8 45.9 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.446 1.098 . . . . 1.0 112.56 174.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.71 64.17 1.92 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.269 -1.132 . . . . 1.0 110.269 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.26 -22.55 1.35 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 168.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -59.89 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 168.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.42 -49.95 87.87 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 114.283 1.216 . . . . 1.0 114.283 -169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.37 -24.98 22.15 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.472 1.562 . . . . 1.0 112.994 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.17 -7.06 57.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.54 1.064 . . . . 1.0 111.74 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.91 -18.02 63.37 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.889 0.876 . . . . 1.0 110.771 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.941 0 CA-C-O 117.052 -1.452 . . . . 1.0 112.517 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.727 0 CA-C-O 120.834 0.349 . . . . 1.0 110.099 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.62 61.57 1.32 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.313 2.245 . . . . 1.0 107.527 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.55 121.64 35.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -136.2 151.83 50.12 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 120.48 21.58 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.075 0 C-N-CA 123.775 0.83 . . . . 1.0 109.766 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -73.51 123.8 24.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.196 1.398 . . . . 1.0 108.223 172.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -141.3 163.55 32.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.145 0.978 . . . . 1.0 109.353 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -139.86 167.82 21.23 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 168.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 20.1 tt0 -59.93 165.46 3.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.312 1.445 . . . . 1.0 109.153 168.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p 71.31 -50.3 0.69 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.864 2.866 . . . . 1.0 114.483 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.9 t -64.07 114.04 12.37 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 119.646 1.112 . . . . 1.0 109.813 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.32 -33.65 6.87 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.293 1.329 . . . . 1.0 111.621 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 89.1 t80 -56.59 -30.65 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.84 1.256 . . . . 1.0 110.755 172.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -56.39 10.34 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.002 0.921 . . . . 1.0 108.821 168.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -57.2 -46.54 82.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.894 0.702 . . . . 1.0 112.894 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -45.47 -45.37 13.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.957 1.303 . . . . 1.0 112.445 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -66.52 -26.88 67.36 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -76.56 -33.49 58.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.61 -0.681 . . . . 1.0 111.191 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -28.84 69.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.121 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD21 ' HE3' ' A' ' 24' ' ' LYS . 6.0 tt -63.73 -58.69 6.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.414 0.686 . . . . 1.0 109.24 171.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -36.86 78.03 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.187 -0.321 . . . . 1.0 111.209 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.5 t -66.36 -43.08 87.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.572 -0.705 . . . . 1.0 110.607 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.6 t -57.87 -27.37 63.19 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.294 0.952 . . . . 1.0 111.743 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HE3' HD21 ' A' ' 20' ' ' LEU . 57.1 mttm -92.56 3.92 54.6 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.13 0.972 . . . . 1.0 112.225 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.1 23.32 76.34 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 118.862 0.755 . . . . 1.0 112.835 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.67 157.9 3.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 119.046 1.423 . . . . 1.0 110.219 -169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.6 m -108.51 114.88 29.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.987 2.115 . . . . 1.0 105.666 171.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -138.67 167.07 22.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.964 1.306 . . . . 1.0 109.209 -174.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -117.03 99.75 7.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.174 2.189 . . . . 1.0 105.146 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tt0 -62.45 141.99 58.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.945 -1.131 . . . . 1.0 107.945 169.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -129.97 98.01 22.41 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 125.529 1.532 . . . . 1.0 107.664 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.63 143.11 61.02 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.237 2.625 . . . . 1.0 112.217 -175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.71 4.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.216 1.406 . . . . 1.0 112.463 168.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 9.1 t70 -70.55 132.25 45.21 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 117.767 -1.573 . . . . 1.0 106.926 168.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.22 -54.17 4.25 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.02 116.03 22.1 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.527 1.164 . . . . 1.0 108.732 -169.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.49 -16.64 15.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.281 1.033 . . . . 1.0 113.647 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.63 -61.41 2.33 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.039 0.836 . . . . 1.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.35 -20.5 63.85 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.956 -0.465 . . . . 1.0 111.858 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.44 -47.59 83.39 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.363 -0.827 . . . . 1.0 108.8 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -64.09 -42.08 97.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.968 0.803 . . . . 1.0 111.087 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -49.6 -51.21 38.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.916 1.235 . . . . 1.0 110.271 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -55.06 -33.23 62.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.878 0.871 . . . . 1.0 112.867 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.8 -47.69 88.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 119.336 0.971 . . . . 1.0 108.674 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -63.51 -46.46 85.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.855 0.752 . . . . 1.0 109.988 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -65.36 -12.89 56.55 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.348 -0.834 . . . . 1.0 112.665 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.5 p -127.0 -38.77 1.99 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.64 29.31 74.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 110.744 -0.942 . . . . 1.0 110.744 -168.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -119.51 -59.9 1.78 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.567 1.183 . . . . 1.0 111.144 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.271 0.4 OUTLIER 88.56 -26.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.686 2.795 . . . . 1.0 112.113 -174.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -81.62 144.61 31.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 120.524 -1.36 . . . . 1.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -97.11 164.97 16.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.429 1.492 . . . . 1.0 111.188 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 36.7 Cg_endo -75.03 168.77 76.43 Favored 'Cis proline' 0 N--CA 1.454 -0.851 0 N-CA-C 108.631 -1.334 . . . . 1.0 108.631 -11.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -144.49 151.24 38.87 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 mp -114.31 148.58 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 104.588 -2.375 . . . . 1.0 104.588 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -128.24 139.42 52.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.607 -1.997 . . . . 1.0 105.607 169.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.8 mt -141.04 145.44 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 105.146 -2.168 . . . . 1.0 105.146 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 55.43 31.2 16.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.468 1.031 . . . . 1.0 111.115 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 14.92 6.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.958 2.503 . . . . 1.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -120.28 150.77 40.18 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.141 1.376 . . . . 1.0 110.142 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -74.28 132.55 42.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.314 1.046 . . . . 1.0 111.361 -173.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mm -74.08 -55.66 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.73 -79.72 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 107.444 -2.262 . . . . 1.0 107.444 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.41 -170.68 33.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 125.482 1.515 . . . . 1.0 110.328 -174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 47.4 t80 -64.95 -52.36 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.448 1.099 . . . . 1.0 111.951 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.28 -41.69 89.5 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.814 -1.18 . . . . 1.0 107.814 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.56 -43.26 85.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.694 1.198 . . . . 1.0 110.298 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 tp -57.73 -48.75 78.71 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 124.317 1.047 . . . . 1.0 110.493 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -52.82 -53.51 47.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.952 0.796 . . . . 1.0 108.988 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.35 87.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 119.799 -0.143 . . . . 1.0 110.749 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -70.85 -33.02 70.22 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.362 1.865 . . . . 1.0 109.928 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.02 -57.61 5.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.171 -0.955 . . . . 1.0 108.869 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.82 59.41 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 115.423 1.638 . . . . 1.0 115.423 -171.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.08 -23.39 44.21 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.12 62.53 1.22 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.259 1.885 . . . . 1.0 110.478 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.29 -18.6 1.3 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 120.32 2.06 . . . . 1.0 112.358 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.58 -65.02 1.05 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 105.662 -1.977 . . . . 1.0 105.662 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -52.21 -52.05 66.2 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.003 1.721 . . . . 1.0 112.836 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.75 -3.7 11.8 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.452 2.102 . . . . 1.0 116.252 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.2 mt -99.59 -31.59 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.922 1.237 . . . . 1.0 110.084 168.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.29 -57.2 9.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.388 1.075 . . . . 1.0 110.442 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 C-N-CA 124.348 1.059 . . . . 1.0 112.064 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . 0.435 HG13 ' CD2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 112.939 0.718 . . . . 1.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -157.87 85.46 0.89 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.884 1.674 . . . . 1.0 109.387 160.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.45 102.73 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 119.941 1.246 . . . . 1.0 107.649 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -113.33 129.07 56.63 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 1.0 106.783 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -114.83 112.24 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 105.92 -1.882 . . . . 1.0 105.92 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -75.85 133.72 40.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.859 1.264 . . . . 1.0 107.778 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -142.57 164.63 29.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.605 0.762 . . . . 1.0 111.396 -173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -142.81 171.38 14.13 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.815 -1.178 . . . . 1.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 2.9 tp10 -65.73 160.9 21.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.647 1.579 . . . . 1.0 109.175 169.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.3 5.0 t 40.65 65.41 0.78 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.458 2.303 . . . . 1.0 111.983 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 27.3 t -145.21 72.31 14.54 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 113.276 0.843 . . . . 1.0 113.276 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.95 -40.47 58.31 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.921 2.414 . . . . 1.0 113.865 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -58.71 -29.64 66.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.034 1.288 . . . . 1.0 111.737 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 45.7 t -75.04 -43.5 53.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 120.602 -1.311 . . . . 1.0 109.325 168.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -62.51 -26.49 68.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.652 1.114 . . . . 1.0 111.795 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.7 mtt-85 -63.35 -47.59 81.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.354 1.861 . . . . 1.0 108.866 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -60.57 -26.35 66.87 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 169.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -76.12 -38.83 56.36 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 118.024 -0.989 . . . . 1.0 111.126 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.27 -26.04 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 119.245 0.93 . . . . 1.0 111.193 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HE1' ' A' ' 65' ' ' TYR . 2.4 tt -65.29 -59.28 4.22 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.4 -0.963 . . . . 1.0 108.4 169.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.5 mt -67.17 -27.06 66.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.061 -0.399 . . . . 1.0 111.915 -173.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.2 t -79.27 -29.84 42.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.851 -1.071 . . . . 1.0 110.237 174.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t -60.79 -38.81 86.57 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.557 1.526 . . . . 1.0 109.021 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HE3' HD21 ' A' ' 20' ' ' LEU . 46.0 mttm -81.1 -6.42 58.8 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.32 1.048 . . . . 1.0 112.6 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.76 41.31 50.63 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 125.072 1.32 . . . . 1.0 112.877 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.76 146.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 118.417 1.108 . . . . 1.0 110.021 -170.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 m -80.83 124.21 28.89 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.503 -1.295 . . . . 1.0 107.503 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -147.57 165.8 29.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.886 1.274 . . . . 1.0 107.619 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -111.74 100.67 9.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -70.63 133.6 46.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.681 -1.6 . . . . 1.0 106.681 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mt -121.92 92.15 48.8 Favored Pre-proline 0 N--CA 1.467 0.385 0 C-N-CA 124.645 1.178 . . . . 1.0 110.18 -170.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -61.24 113.05 1.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.612 3.541 . . . . 1.0 111.695 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 HD11 ' CG1' ' A' ' 52' ' ' VAL . 3.0 pt -107.16 9.02 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 127.319 2.248 . . . . 1.0 112.155 175.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 9' ' ' GLU . 10.9 t70 -77.82 -53.8 7.08 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 119.423 -0.911 . . . . 1.0 108.753 168.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.58 -22.99 75.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.63 -0.539 . . . . 1.0 112.955 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -123.98 110.92 15.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.949 1.699 . . . . 1.0 108.21 -172.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -26.27 32.55 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.067 0.947 . . . . 1.0 111.967 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.82 -62.42 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.767 1.227 . . . . 1.0 110.394 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' HB3' HD21 ' A' ' 36' ' ' ASN . 9.1 ttmm -67.41 -19.68 65.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.841 -0.537 . . . . 1.0 111.407 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -65.78 -48.23 72.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 119.359 0.982 . . . . 1.0 108.541 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.45 -28.18 68.4 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 118.853 -0.594 . . . . 1.0 111.061 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.73 -51.47 67.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.019 -0.991 . . . . 1.0 109.898 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.3 ttp -53.23 -44.02 67.77 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.805 1.184 . . . . 1.0 110.77 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.4 mt -56.52 -58.41 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -60.78 -32.98 72.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.248 0.931 . . . . 1.0 112.437 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -20.31 65.42 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.905 2.082 . . . . 1.0 113.311 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -131.29 -27.05 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.305 1.594 . . . . 1.0 115.305 -169.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.42 -2.4 85.24 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.155 1.36 . . . . 1.0 111.898 -168.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -120.56 149.37 42.55 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 120.252 2.026 . . . . 1.0 110.728 -172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.6 p -111.34 -19.95 12.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.421 -0.799 . . . . 1.0 112.238 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.0 p -78.14 150.72 33.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.339 0.972 . . . . 1.0 111.439 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -113.33 159.33 35.52 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.675 2.39 . . . . 1.0 109.964 176.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 52' ' ' VAL . 71.3 Cg_endo -68.07 167.49 63.51 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.279 1.136 . . . . 1.0 110.551 -3.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -142.96 151.28 40.74 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 168.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.9 mp -125.98 146.11 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 105.727 -1.953 . . . . 1.0 105.727 -177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.35 127.33 39.19 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.425 -2.435 . . . . 1.0 104.425 171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.4 mt -122.61 126.02 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 50.94 44.15 28.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.495 1.617 . . . . 1.0 109.042 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 55.21 -2.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 1 C-N-CA 132.093 4.157 . . . . 1.0 115.615 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -77.5 122.92 25.89 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.87 1.214 . . . . 1.0 108.719 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -62.58 133.01 54.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.86 0.864 . . . . 1.0 109.829 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -87.07 -59.51 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.72 -156.81 26.95 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 106.022 -2.831 . . . . 1.0 106.022 -168.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.6 -156.11 30.7 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.788 1.185 . . . . 1.0 112.322 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 7.3 t80 -65.78 -57.14 8.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.03 1.332 . . . . 1.0 110.859 -176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -36.1 71.56 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.483 0.713 . . . . 1.0 109.764 -176.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.9 -55.94 16.33 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.4 1.48 . . . . 1.0 108.68 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.6 tp -54.22 -47.94 71.61 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.308 1.043 . . . . 1.0 110.265 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -52.68 -53.24 50.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.525 1.53 . . . . 1.0 111.481 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.03 95.39 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.178 0.191 . . . . 1.0 110.77 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.84 -37.3 85.84 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.737 0.78 . . . . 1.0 109.998 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.89 -51.3 67.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.044 1.338 . . . . 1.0 110.632 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.39 -26.08 66.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -15.41 58.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.391 0.541 . . . . 1.0 112.294 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 41.22 56.8 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.315 -1.269 . . . . 1.0 110.953 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -106.98 -20.08 9.06 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.764 1.782 . . . . 1.0 111.327 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -53.88 9.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 105.304 -2.11 . . . . 1.0 105.304 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -42.68 -56.43 5.93 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.601 2.36 . . . . 1.0 113.534 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.08 -17.1 12.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.903 2.402 . . . . 1.0 114.946 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.52 -17.74 62.95 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.716 1.144 . . . . 1.0 110.014 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.44 26.05 0.08 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.694 1.598 . . . . 1.0 110.328 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 O-C-N 119.717 -1.864 . . . . 1.0 111.171 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.951 0.881 . . . . 1.0 112.571 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -144.34 71.45 1.31 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.02 120.02 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 105.212 -2.144 . . . . 1.0 105.212 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.17 144.24 50.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 106.146 -1.798 . . . . 1.0 106.146 171.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tt -133.26 119.18 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.652 -1.611 . . . . 1.0 106.652 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -73.91 125.28 27.85 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.721 -1.127 . . . . 1.0 108.035 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -132.92 166.4 22.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.517 1.127 . . . . 1.0 110.483 -173.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -143.04 150.62 39.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.78 -59.85 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.525 0.73 . . . . 1.0 110.463 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 t -100.0 86.24 3.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.142 -1.799 . . . . 1.0 106.142 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.4 t -161.33 96.06 1.34 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 125.313 1.445 . . . . 1.0 107.224 168.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.4 -31.36 72.61 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 CA-C-N 120.297 1.142 . . . . 1.0 112.683 -170.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -63.69 -39.99 95.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.83 1.652 . . . . 1.0 111.652 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.5 t -57.96 -42.78 85.71 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 64.5 m-70 -68.87 -35.95 77.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.322 -0.951 . . . . 1.0 111.997 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -50.6 -40.02 51.56 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.643 0.777 . . . . 1.0 113.042 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' CE1' ' A' ' 65' ' ' TYR . . . -59.02 -26.79 64.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.441 1.275 . . . . 1.0 114.441 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -76.21 -34.01 59.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.453 0.57 . . . . 1.0 111.302 178.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.99 76.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 117.889 -1.053 . . . . 1.0 110.754 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -58.6 5.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.476 1.035 . . . . 1.0 109.114 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -58.67 -39.62 81.17 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.081 0.553 . . . . 1.0 111.073 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -65.27 -40.59 94.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.669 0.668 . . . . 1.0 110.917 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -18.2 28.96 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.183 0.902 . . . . 1.0 112.87 173.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -111.54 7.6 20.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.84 1.256 . . . . 1.0 112.868 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.74 21.4 74.9 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.165 0.888 . . . . 1.0 113.083 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 t -84.16 149.7 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.908 1.354 . . . . 1.0 110.108 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 m -99.95 132.59 45.21 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.457 1.503 . . . . 1.0 108.252 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -139.1 142.95 38.1 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.067 0.947 . . . . 1.0 109.026 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -83.84 88.93 7.12 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.733 -2.691 . . . . 1.0 103.733 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.2 140.38 58.74 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -133.13 86.12 43.16 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.301 1.44 . . . . 1.0 109.537 -171.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.46 123.84 14.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 1 C-N-CA 125.902 4.401 . . . . 1.0 111.113 176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.254 3.3 pt -122.52 36.4 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.09 1.356 . . . . 1.0 113.531 -175.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.1 143.73 51.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 167.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.83 -51.82 4.5 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 106.487 -2.645 . . . . 1.0 106.487 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.445 HD21 ' H ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -83.71 115.83 22.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.067 1.747 . . . . 1.0 107.022 168.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.45 -25.76 10.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.522 -0.751 . . . . 1.0 112.195 169.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -59.66 5.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.532 1.06 . . . . 1.0 111.668 -175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' H ' HD21 ' A' ' 36' ' ' ASN . 11.0 ttmm -60.08 -30.58 69.33 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.663 -0.648 . . . . 1.0 112.024 173.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -60.56 -47.09 87.71 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.808 1.185 . . . . 1.0 108.855 173.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -62.95 -39.71 95.46 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.141 0.976 . . . . 1.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.39 -50.6 73.31 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.701 -0.852 . . . . 1.0 108.701 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.4 tmm? -60.7 -37.57 82.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.684 1.593 . . . . 1.0 112.128 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mt -55.19 -36.92 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 119.508 1.049 . . . . 1.0 109.685 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -64.87 -51.37 62.35 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.317 -0.865 . . . . 1.0 110.24 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -61.24 -48.23 82.42 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.02 0.528 . . . . 1.0 111.679 -176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 p -73.96 -22.25 59.71 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.808 -0.557 . . . . 1.0 111.589 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.21 15.91 63.87 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.824 -0.987 . . . . 1.0 111.923 -169.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -139.94 171.07 14.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.076 1.75 . . . . 1.0 107.938 -170.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -127.82 -15.21 4.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 122.969 0.507 . . . . 1.0 110.884 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -74.17 169.16 18.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.975 0.807 . . . . 1.0 110.615 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.92 160.69 53.06 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.295 1.838 . . . . 1.0 108.274 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.55 168.65 75.63 Favored 'Cis proline' 0 N--CA 1.451 -0.972 0 CA-C-N 119.999 1.035 . . . . 1.0 110.697 -6.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -139.66 130.28 25.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.403 -2.443 . . . . 1.0 104.403 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.12 143.64 23.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 105.797 -1.927 . . . . 1.0 105.797 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 137.17 47.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.135 -1.802 . . . . 1.0 106.135 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 39.0 mt -132.76 119.51 38.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 46.01 48.55 12.47 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.997 1.38 . . . . 1.0 110.187 -174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 72.01 -15.18 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 130.622 3.569 . . . . 1.0 114.668 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.06 118.94 18.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.638 1.108 . . . . 1.0 109.046 -177.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -61.76 148.67 42.2 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.748 -0.595 . . . . 1.0 109.841 173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.97 -81.46 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.85 -59.16 0.11 Allowed Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.661 -1.775 . . . . 1.0 108.661 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.74 -166.38 36.07 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.028 2.251 . . . . 1.0 108.159 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 43.3 t80 -71.88 -49.71 35.61 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 117.695 -1.145 . . . . 1.0 110.972 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -60.68 -39.79 89.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.611 1.096 . . . . 1.0 108.447 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -59.65 -52.24 66.37 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.691 0.796 . . . . 1.0 109.025 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.75 -43.2 99.32 Favored 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.622 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.67 -53.56 50.24 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 -175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.77 95.01 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.102 -0.333 . . . . 1.0 110.102 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.4 -44.7 95.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.258 1.027 . . . . 1.0 110.05 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -74.09 -31.81 62.98 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 119.871 -1.768 . . . . 1.0 109.889 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.63 -25.95 64.18 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.672 -1.268 . . . . 1.0 112.934 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -8.65 59.19 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.111 0.964 . . . . 1.0 111.762 169.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 26.88 70.96 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.847 1.213 . . . . 1.0 112.103 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.17 -12.75 51.23 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 119.68 1.74 . . . . 1.0 112.243 -174.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -46.64 44.86 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 106.149 -1.797 . . . . 1.0 106.149 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -47.74 89.01 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 115.036 1.495 . . . . 1.0 115.036 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.4 -11.9 30.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.076 1.85 . . . . 1.0 114.454 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 mt -85.55 -5.63 59.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.349 0.977 . . . . 1.0 111.345 171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.47 21.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 110.144 172.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.431 1.892 . . . . 1.0 107.915 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 121.532 0.682 . . . . 1.0 109.244 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -103.16 60.59 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 105.122 -2.177 . . . . 1.0 105.122 -171.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.75 80.95 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 105.096 -2.187 . . . . 1.0 105.096 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.57 142.07 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.438 HG21 ' HE3' ' A' ' 18' ' ' LYS . 11.6 tt -129.8 115.51 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 31' ' ' LEU . 23.4 m-85 -73.72 138.1 44.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 170.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -147.32 159.99 43.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 1.0 109.068 -169.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -140.58 165.03 28.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 168.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -66.18 -58.98 4.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 t -80.72 64.92 5.67 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.727 1.251 . . . . 1.0 109.833 -172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.0 t -158.39 96.02 1.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.159 . . . . 1.0 109.166 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.85 -35.69 66.07 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.664 1.576 . . . . 1.0 111.449 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CE2' ' HA1' ' A' ' 83' ' ' GSH . 39.3 t80 -56.49 -33.6 66.13 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.894 1.277 . . . . 1.0 111.615 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.6 t -63.58 -51.39 65.56 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.188 -0.945 . . . . 1.0 109.027 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.72 -29.28 67.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.839 0.745 . . . . 1.0 112.193 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -59.84 -46.2 90.02 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.895 1.278 . . . . 1.0 110.423 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.54 -23.09 66.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.07 0.767 . . . . 1.0 113.07 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' HG21 ' A' ' 5' ' ' ILE . 7.2 mmmm -75.85 -44.77 39.23 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 117.66 -1.162 . . . . 1.0 110.507 173.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.14 -37.86 67.49 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.614 0.643 . . . . 1.0 110.136 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -60.7 -62.64 1.71 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.561 0.618 . . . . 1.0 109.778 172.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 68' ' ' LEU . 13.7 mt -57.16 -36.0 70.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.864 0.756 . . . . 1.0 112.433 -175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.7 m -80.14 -30.3 38.97 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.732 1.151 . . . . 1.0 112.193 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.9 t -65.92 -36.71 84.11 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.194 1.361 . . . . 1.0 110.349 171.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 20' ' ' LEU . 60.2 mmtt -74.95 -29.23 60.88 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.1 -1.0 . . . . 1.0 110.821 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.83 69.41 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.696 . . . . 1.0 110.161 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 144.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.191 0.996 . . . . 1.0 110.697 -178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 m -73.99 73.97 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.364 1.866 . . . . 1.0 111.528 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -76.22 161.49 28.74 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.722 -0.611 . . . . 1.0 110.759 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -121.91 97.81 5.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.986 2.914 . . . . 1.0 105.082 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -72.84 134.27 44.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 6' ' ' TYR . 19.1 mt -127.89 102.73 21.84 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.619 1.568 . . . . 1.0 108.4 -175.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -79.46 125.2 6.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.215 3.277 . . . . 1.0 111.243 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.7 22.84 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 126.856 2.062 . . . . 1.0 110.4 169.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.98 -51.33 26.26 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.719 -1.238 . . . . 1.0 111.442 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.45 15.19 46.45 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.674 1.607 . . . . 1.0 111.815 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 ' HB3' ' A' ' 39' ' ' LYS . 1.2 t30 -126.76 99.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.399 1.879 . . . . 1.0 108.187 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.23 -24.09 19.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.488 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.09 -51.78 54.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.372 0.987 . . . . 1.0 110.956 -175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 36' ' ' ASN . 19.5 ttpt -72.1 -21.95 61.41 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.508 -0.745 . . . . 1.0 110.833 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -59.78 -48.24 82.48 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.591 1.087 . . . . 1.0 108.761 168.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.5 -34.21 76.42 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.288 0.949 . . . . 1.0 111.103 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -65.95 -43.89 86.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 29.4 ttp -63.72 -45.85 88.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 116.661 -1.638 . . . . 1.0 110.805 171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -50.49 -41.36 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 121.013 1.733 . . . . 1.0 109.374 -178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.68 -65.36 0.63 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -68.23 -11.72 59.79 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.124 1.527 . . . . 1.0 115.124 -168.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.1 p -114.83 -24.93 8.43 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.674 1.19 . . . . 1.0 113.844 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.3 10.39 74.37 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.492 -1.171 . . . . 1.0 112.852 -168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -134.59 145.21 48.46 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.321 2.061 . . . . 1.0 111.287 -175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -98.2 -19.22 18.0 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.759 0.824 . . . . 1.0 110.858 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.0 p -74.23 167.74 21.01 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.458 1.503 . . . . 1.0 111.529 -173.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.66 163.16 53.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.605 1.162 . . . . 1.0 111.947 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.88 161.61 93.91 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 CA-C-N 118.851 0.626 . . . . 1.0 110.731 -6.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -136.68 147.38 46.78 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.38 149.99 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.048 -1.834 . . . . 1.0 106.048 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -133.39 143.04 48.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.671 -1.974 . . . . 1.0 105.671 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.0 mt -130.98 125.96 58.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 106.291 -1.744 . . . . 1.0 106.291 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.6 28.56 12.11 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.558 1.17 . . . . 1.0 111.259 -168.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 74.73 -6.0 2.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 130.639 3.576 . . . . 1.0 114.138 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.58 128.34 34.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.835 1.654 . . . . 1.0 108.875 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -73.82 138.2 44.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.357 -0.839 . . . . 1.0 111.745 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.65 -44.52 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 C-N-CA 123.579 0.752 . . . . 1.0 109.353 173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.85 -103.54 0.48 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.553 -1.819 . . . . 1.0 108.553 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 67' ' ' ASP . . . -130.37 -160.79 10.17 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.504 2.002 . . . . 1.0 111.043 -175.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.46 -56.18 13.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.763 1.625 . . . . 1.0 109.456 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -62.71 -39.51 94.28 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -56.58 -54.29 47.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.496 -1.298 . . . . 1.0 107.496 174.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 21' ' ' LEU . 39.4 tp -58.8 -54.25 49.26 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.806 -1.092 . . . . 1.0 112.731 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -46.17 -53.35 10.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.343 1.457 . . . . 1.0 110.289 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.95 83.5 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -60.08 -36.74 78.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.5 1.92 . . . . 1.0 111.088 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.06 -59.48 3.01 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.954 2.102 . . . . 1.0 108.881 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.04 67.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 118.787 -0.625 . . . . 1.0 112.355 -168.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -5.7 56.72 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.201 1.401 . . . . 1.0 113.911 173.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.56 54.17 4.74 Favored Glycine 0 N--CA 1.447 -0.593 0 O-C-N 121.518 -0.739 . . . . 1.0 111.477 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.4 -35.9 1.69 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.16 -1.976 . . . . 1.0 108.16 168.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.01 61.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -48.87 -59.22 6.66 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 117.914 -1.041 . . . . 1.0 112.798 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -20.19 26.61 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.739 1.626 . . . . 1.0 113.671 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.61 -24.47 61.08 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.863 1.21 . . . . 1.0 112.043 175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.54 -57.61 11.93 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.353 1.061 . . . . 1.0 110.372 -170.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 129.145 2.978 . . . . 1.0 112.272 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . 0.477 ' HA1' ' CE2' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.057 0.456 . . . . 1.0 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.0 63.08 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.785 -1.932 . . . . 1.0 105.785 173.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.49 109.99 16.36 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 N-CA-C 107.092 -1.447 . . . . 1.0 107.092 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -117.8 132.72 56.41 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.317 -1.364 . . . . 1.0 107.317 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tt -123.12 108.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 126.312 1.845 . . . . 1.0 106.256 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -73.53 134.31 43.8 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.0 p -132.77 168.76 17.76 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.481 1.112 . . . . 1.0 109.584 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -138.48 155.54 48.34 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -66.02 176.12 1.8 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p 54.83 11.96 0.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 128.651 2.78 . . . . 1.0 116.116 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 39.0 t -133.42 115.61 13.8 Favored Pre-proline 0 C--O 1.239 0.505 0 O-C-N 120.744 -1.222 . . . . 1.0 110.491 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -32.45 15.8 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 CA-C-O 116.973 -1.344 . . . . 1.0 111.893 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB3' ' SG2' ' A' ' 83' ' ' GSH . 54.6 t80 -57.59 -29.79 64.75 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 121.765 2.075 . . . . 1.0 111.12 176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -51.09 62.22 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.027 -1.046 . . . . 1.0 109.632 169.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -57.98 -48.99 78.33 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.481 0.919 . . . . 1.0 113.481 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -54.29 -34.17 60.34 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.502 2.321 . . . . 1.0 111.405 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.78 -26.31 63.28 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.809 1.04 . . . . 1.0 113.809 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -38.86 58.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.05 0.841 . . . . 1.0 109.435 170.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.47 -31.14 69.06 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.369 -0.824 . . . . 1.0 110.982 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -61.26 2.76 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.113 0.869 . . . . 1.0 109.885 172.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.78 -45.23 70.62 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.016 0.927 . . . . 1.0 110.62 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -60.7 -46.63 89.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.655 1.582 . . . . 1.0 110.234 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -33.01 69.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.749 1.159 . . . . 1.0 110.53 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -93.37 1.75 56.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.434 0.694 . . . . 1.0 112.294 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.37 36.27 83.93 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.406 1.003 . . . . 1.0 112.426 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.68 155.64 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 118.224 1.012 . . . . 1.0 108.51 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 m -113.9 125.63 54.27 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.648 1.579 . . . . 1.0 107.634 -173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.34 -178.58 6.3 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.481 1.512 . . . . 1.0 110.894 -168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -130.91 104.16 6.98 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.239 2.216 . . . . 1.0 106.101 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.06 139.12 58.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 mt -131.68 80.95 65.08 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 125.363 1.465 . . . . 1.0 108.958 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -61.21 116.9 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 124.077 3.185 . . . . 1.0 110.022 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 pt -113.73 50.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.743 2.017 . . . . 1.0 108.336 171.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -93.71 131.1 39.37 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.213 -1.358 . . . . 1.0 109.147 169.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.09 -30.38 1.59 Allowed Glycine 0 CA--C 1.531 1.031 0 C-N-CA 124.89 1.233 . . . . 1.0 113.681 172.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.416 HD21 ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -83.57 117.5 23.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.054 -1.832 . . . . 1.0 106.054 170.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.9 -22.38 22.03 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 118.864 -0.589 . . . . 1.0 112.388 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.68 -68.27 0.36 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.667 0.787 . . . . 1.0 110.404 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' CB ' HD21 ' A' ' 36' ' ' ASN . 6.2 ttpt -66.75 -23.84 66.14 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.102 -0.999 . . . . 1.0 111.707 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -56.77 -55.24 36.77 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 118.775 0.716 . . . . 1.0 109.203 168.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -71.17 -25.4 62.53 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.208 0.913 . . . . 1.0 111.893 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -63.42 -45.04 92.82 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.599 -0.688 . . . . 1.0 109.367 170.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.1 ttp -59.85 -38.68 82.79 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.575 -0.726 . . . . 1.0 110.185 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.18 -53.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -55.56 -49.23 73.26 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.256 0.934 . . . . 1.0 111.837 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -60.03 -17.5 39.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 117.458 -1.258 . . . . 1.0 113.43 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.2 p -120.38 -18.2 7.98 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 114.567 1.321 . . . . 1.0 114.567 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.94 18.94 62.82 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.07 -0.85 . . . . 1.0 112.334 -169.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -136.24 144.53 44.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.718 1.759 . . . . 1.0 107.746 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.5 m -89.22 -27.23 20.77 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -75.63 143.4 42.27 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 119.594 -0.843 . . . . 1.0 110.347 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 53' ' ' PRO . 4.2 m -98.7 167.77 10.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.403 1.081 . . . . 1.0 109.141 172.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 86.2 Cg_endo -71.28 169.52 68.73 Favored 'Cis proline' 0 N--CA 1.46 -0.465 0 CA-C-N 120.176 1.098 . . . . 1.0 109.722 -11.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -137.14 141.16 42.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.06 147.78 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.7 137.25 45.19 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.191 -2.152 . . . . 1.0 105.191 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.7 mt -136.34 121.17 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 104.702 -2.333 . . . . 1.0 104.702 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 44.83 47.88 9.08 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.696 1.236 . . . . 1.0 110.354 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.72 -3.86 0.2 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 130.384 3.474 . . . . 1.0 116.2 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -74.32 139.98 44.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 171.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -85.63 144.85 27.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.7 mm -87.92 -77.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.673 0.389 . . . . 1.0 110.023 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.84 -37.88 0.61 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.217 0.913 . . . . 1.0 111.509 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 162.03 -168.07 36.94 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -60.61 2.34 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 125.568 1.547 . . . . 1.0 109.955 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -35.86 74.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.157 0.889 . . . . 1.0 109.728 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.75 -50.11 73.7 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.57 -44.06 91.89 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 118.483 0.583 . . . . 1.0 111.053 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -50.74 -53.7 29.43 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.769 1.627 . . . . 1.0 108.847 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.92 -41.3 97.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.777 0.431 . . . . 1.0 110.009 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.75 -42.28 88.51 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.998 0.904 . . . . 1.0 110.273 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.76 -39.87 56.33 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.233 -0.917 . . . . 1.0 109.794 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.99 64.31 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.235 -0.915 . . . . 1.0 112.848 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -9.46 58.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 117.661 -1.161 . . . . 1.0 112.014 170.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.34 30.53 64.65 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 118.532 -1.149 . . . . 1.0 111.852 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.34 -11.75 14.86 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.082 1.441 . . . . 1.0 112.216 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.63 -45.5 52.48 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 106.186 -1.783 . . . . 1.0 106.186 173.084 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.25 -50.58 78.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-O 118.725 -0.655 . . . . 1.0 112.705 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.57 -16.8 43.09 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.3 1.5 . . . . 1.0 113.614 175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.22 -21.43 39.56 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.071 1.305 . . . . 1.0 111.483 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.49 -53.54 18.67 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.035 1.288 . . . . 1.0 110.128 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.381 2.272 . . . . 1.0 116.199 -168.47 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . 0.47 ' SG2' ' HB3' ' A' ' 13' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.659 0.266 . . . . 1.0 110.812 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.1 74.78 1.48 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 127.235 2.214 . . . . 1.0 106.333 -173.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.5 t -78.73 121.47 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.98 146.28 41.38 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 169.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 tt -129.28 109.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.053 1.341 . . . . 1.0 108.236 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.29 134.86 42.59 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.971 1.308 . . . . 1.0 107.689 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -148.19 159.35 44.04 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.961 0.904 . . . . 1.0 110.802 -172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.54 156.94 43.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 103.604 -2.739 . . . . 1.0 103.604 168.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -66.84 176.1 2.17 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.583 1.083 . . . . 1.0 112.127 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.275 14.1 t 48.3 44.63 20.02 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.659 1.984 . . . . 1.0 110.52 169.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.9 t -138.95 94.07 10.19 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.108 1.763 . . . . 1.0 107.486 -169.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.77 -30.99 26.41 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.255 1.303 . . . . 1.0 112.653 -172.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -59.83 -39.06 83.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.642 1.11 . . . . 1.0 110.223 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -65.82 -49.81 66.87 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.518 -0.739 . . . . 1.0 110.144 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.55 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 10.9 m-70 -62.26 -41.61 98.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.559 1.072 . . . . 1.0 110.991 -175.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -47.96 -53.25 16.65 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.97 1.708 . . . . 1.0 110.88 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.5 67.71 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.743 1.016 . . . . 1.0 113.743 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -72.2 -44.37 63.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.874 0.761 . . . . 1.0 110.676 175.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.36 70.74 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.703 172.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.26 -57.78 10.98 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.612 1.096 . . . . 1.0 109.105 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -55.35 -45.66 76.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 119.154 -0.45 . . . . 1.0 111.617 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 m -68.29 -37.32 80.53 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.307 -0.854 . . . . 1.0 112.109 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -57.27 -44.82 84.28 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.917 1.235 . . . . 1.0 109.368 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -74.01 -2.78 25.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.031 1.332 . . . . 1.0 112.484 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.81 14.07 82.49 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.759 1.163 . . . . 1.0 112.288 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.37 161.17 3.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 118.982 1.391 . . . . 1.0 107.614 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.3 m -121.86 113.2 19.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.1 1.76 . . . . 1.0 106.717 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -122.86 167.27 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.347 0.521 . . . . 1.0 112.166 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -119.08 99.76 6.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.152 -2.536 . . . . 1.0 104.152 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -65.79 146.23 55.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.415 0.626 . . . . 1.0 109.339 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 mt -136.19 82.52 35.37 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 126.388 1.875 . . . . 1.0 108.74 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.17 121.17 9.52 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 125.094 3.863 . . . . 1.0 109.936 171.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD11 HG11 ' A' ' 52' ' ' VAL . 2.1 pp -114.97 21.93 6.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 127.298 2.239 . . . . 1.0 111.316 174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -80.97 -72.1 0.44 Allowed 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.293 -0.879 . . . . 1.0 108.674 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.39 23.38 1.91 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.098 1.808 . . . . 1.0 112.498 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.39 82.65 1.42 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.023 2.129 . . . . 1.0 106.851 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.53 -14.74 60.85 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.773 -0.579 . . . . 1.0 111.578 172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.98 -63.93 1.06 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.866 0.757 . . . . 1.0 110.669 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -67.27 -18.02 65.03 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.9 -0.5 . . . . 1.0 111.396 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -46.81 75.64 Favored 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 121.433 -0.792 . . . . 1.0 109.337 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -70.46 -33.83 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.157 0.583 . . . . 1.0 110.631 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.11 -51.28 69.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 172.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 ttp -58.48 -43.58 89.0 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 117.106 -1.426 . . . . 1.0 111.162 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.02 -47.5 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 121.114 1.779 . . . . 1.0 109.237 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -60.34 -59.31 5.61 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 118.799 -0.62 . . . . 1.0 109.616 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.284 6.9 ptp180 -70.04 -28.81 65.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.84 1.422 . . . . 1.0 114.84 -170.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -98.9 -21.33 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.6 0.963 . . . . 1.0 113.6 -170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.89 58.95 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.337 -0.702 . . . . 1.0 113.425 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -132.84 161.68 33.53 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.396 1.478 . . . . 1.0 109.06 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -114.34 -35.21 5.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.522 -0.547 . . . . 1.0 109.522 -170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.9 p -91.46 150.53 21.2 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 113.134 0.791 . . . . 1.0 113.134 -168.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 33' ' ' ILE . 2.1 m -91.35 162.37 32.18 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.525 1.53 . . . . 1.0 111.94 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.27 158.88 98.1 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.991 -0.837 . . . . 1.0 110.003 -8.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.73 147.33 46.67 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 106.296 -1.742 . . . . 1.0 106.296 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.69 147.1 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -131.3 145.5 51.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.178 1.791 . . . . 1.0 106.488 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.3 mt -135.08 105.78 6.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.951 -2.24 . . . . 1.0 104.951 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 58.39 35.45 24.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.351 1.06 . . . . 1.0 111.089 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 90.28 -12.97 0.3 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 130.785 3.634 . . . . 1.0 113.332 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.23 130.19 39.27 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 106.768 -1.567 . . . . 1.0 106.768 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -85.52 123.58 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mm -78.9 -51.33 17.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.32 -144.6 15.81 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 105.655 -2.978 . . . . 1.0 105.655 -168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.32 -153.19 29.24 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.577 1.561 . . . . 1.0 111.56 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -72.08 -56.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.641 1.576 . . . . 1.0 110.493 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.38 -31.24 72.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.05 -55.44 34.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -63.97 -46.54 84.19 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 118.566 -0.73 . . . . 1.0 111.704 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -52.66 -53.21 50.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.966 0.803 . . . . 1.0 109.814 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.09 93.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.013 -0.518 . . . . 1.0 110.51 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.97 -39.16 90.14 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.855 0.862 . . . . 1.0 110.106 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.36 -56.51 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 120.675 -1.266 . . . . 1.0 108.794 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -10.5 34.86 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -10.4 50.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.862 1.21 . . . . 1.0 112.196 168.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.12 52.72 6.08 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 126.283 1.897 . . . . 1.0 111.003 -171.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -120.45 -25.64 2.37 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.503 2.151 . . . . 1.0 111.557 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.96 -57.39 4.0 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.785 -1.561 . . . . 1.0 106.785 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -53.77 -47.0 98.17 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.49 -10.41 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.492 1.569 . . . . 1.0 115.201 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.08 -9.88 54.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.76 1.618 . . . . 1.0 110.88 168.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -84.9 36.57 0.62 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.899 1.68 . . . . 1.0 110.166 172.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_